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Abstract 
The importance of CD8+ T cells in the control of HIV/SIV infection has been 
extensively reported. However, the reason why CD8+ T cells do not sufficiently control 
or clear virus is unknown. Importantly, cytolytic properties of CD8+ T cells are highly 
correlated with control of HIV/SIV infection as demonstrated in elite controller subjects 
yet are poorly maintained in chronically infected subjects. In addition, reduced killing 
functions by lymph node CD8+ T cells as compared to blood CD8+ T cells have been 
described during chronic HIV infection suggesting a semi-immune privilege environment 
of lymph nodes. To date, the evolution of cytolytic SIV-specific CD8+ T cells in 
anatomical compartments associated with viral reservoir and replication has not been 
thoroughly evaluated. As such, we implemented the Rhesus macaque SIV infection 
model to characterize the evolution and tissue-distribution of cytolytic SIV-specific 
memory CD8+ T cells during acute infection. We found robust acute phase cytolytic 
potential to be short-lived, in part consequential of low levels of T-bet, in all evaluated 
tissues though most pronounce in secondary lymphoid tissues.  In addition, we observed 
the lowest frequencies of effector memory differentiated SIV-specific CD8+ T cells 
within secondary lymphoid tissues as compared to the circulation, even during peak 
viremia. Moreover, secondary lymphoid tissues appear to provide an environment with 
reduced cytotoxic effector CD8+ T cell pressures that is favorable for viral reservoir 
formation and persistent viral replication in these tissues. 
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Chapter 1:  Thesis Introduction 
Chapter 1.1 Immunological memory and the adaptive immune system: a brief 
overview 
One of the most astounding aspects of the mammalian immune system is the 
potential for and actualization of memory to nearly all encountered foreign antigens 
termed immunological memory.  This attribute of immunity affords life long recognition 
and protection upon repeat exposure to foreign or altered-self antigens.  Immunological 
memory is a unique and key feature of vertebrate immunity that separates the adaptive 
from the innate, or pre-established and fixed, arm of immune functions.  As such, 
immunological memory may be the most critical physiological component fostering 
persistence of mammalian organisms despite the rapid evolution of pathogens such as 
bacteria and viruses. Both T and B lymphocytes are cells of the adaptive immune system 
that display features of immunological memory and can persist for the duration of the 
host’s life following primary encounter with cognate antigen.  
Chapter 1.1.1 T and B cells in Immunological memory 
The CD4+ T cell, otherwise known as the helper T cell, is instrumental in 
development of immunological memory by directing adaptive immune responses and 
ultimately long term antigenic memory.  To this end, CD4+T cells help in the selection 
and activation of naive CD8+ T cells and driving subsequent effector and memory CD8+ 
T cell functions (1, 2).  At the same time, CD4+ helper T cells are essential for the 
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selection and activation of naïve B cells as well as the intricate process of stochastically 
refining the affinity of the B cell receptor for its recognized antigen within germinal 
centers. Following selection, activation and help from CD4+ T cells, both B cells and 
CD8+ T cells can establish immunological memory (3). To our current knowledge, B 
cells and the antibodies B cells produce do not directly mediate clearance of infected or 
altered-self cells, but serve as a means to opsonize or tag pathogens, pathogen infected 
cells or altered-self cells for clearance by phagocytic cells of the innate immune system 
such as macrophage and neutrophils. However, activated memory CD8+ T cells can 
directly mediate clearance of infected or altered-self cells through direct and indirect 
mechanisms that include contact dependent transfer of cytolytic factors to the target cell 
or contact independent passive transfer of secreted antiviral factors (4-8).   
Following clearance of a target cell, activated B cells and T cells undergo a 
transition to a less activated and more quiescent memory state (9).  The loss of effector 
CD8+ T cells or antibody producing short-lived plasma cells following resolution of 
infection contributes to immune homeostasis in the host.  Nevertheless, established 
memory responses can easily be reactivated upon re-exposure to the pathogen or antigen 
for many years if not the remainder of the life of the organism (10-12).   
Chapter 1.1.2 Application of Immunological memory 
The natural phenomenon of immunological memory in response to pathogens had 
been documented for thousands of years without any understanding of its etiology or 
development. Even during the first vaccination strategies via inoculation of a natural but 
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less virulent strain of poxvirus, how vaccinated hosts established long-lived immunity 
was unclear (13).  Knowing the potential for developing life-long immunity has for years 
promoted the use of vaccinations with live attenuated or heat killed pathogens by 
clinicians.  For many endemic pathogens, vaccination strategies have been useful in 
preventing epidemics and major health complications following infection, as was seen 
with small pox, measles and polio infections (13, 14). More recently, vaccinations against 
oncogenic viruses have been successful in reducing the incidence of cancer related to 
viral infections, most notably from Human papilloma viruses (HPV) (15, 16). However, 
the unfathomable nearly perfect and beautifully orchestrated phenomenon of long-lasting 
protective immunity has faltered following exposure to some pathogens including chronic 
viral infections (Discussed in Chapter 1.5) and otherwise altered-self cells including 
cancer (17). 
This thesis characterizes the acute phase development of CD8+ T cell memory to 
SIV infection in critical anatomical compartments including blood, secondary 
lymphoid tissue and gut mucosa. 
Chapter 1.2 Generating CD8+ T cell memory 
Chapter 1.2.1 Encountering cognate antigen 
Following maturation in the thymus, naïve CD8+ T cells drain to the circulating 
peripheral blood en route to secondary lymphoid tissue (SLT) (lymph nodes, spleen and 
gut associated lymphoid structures) in an effort to identify and interact with cognate 
antigen present by an antigen presenting cell (APC) (Figure 1-1) (18).  Naïve CD8+ T 
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cells diapedese, or migrate out, from the blood through high endothelial venules (HEV) 
into lymphoid tissues and ultimately to the lymphatic system (19, 20).  The extravasation 
and trafficking of naïve and central memory CD8+ T cells to secondary lymphoid organs 
through HEV is in part mediated by CD62L binding to peripheral node addressin 
expressed on HEV and chemotaxis via expressed CCR7 for CCL19 and CCL21 released 
by HEV (19, 20). Upon arrival in SLTs, naïve CD8+ T cells migrate through the 
subcapsulary sinus into the medulla and finally to the T cell zone with the intention to 
interact with cognate antigen presented on APC (21).  If a naïve CD8+ T cell encounters 
cognate antigen presented on MHC class I through an interaction with its T cell receptor 
(TCR), CD8+ T cell differentiation beings.  If a naïve CD8+ T cell otherwise fails to 
encounter cognate antigen- MHC I within 7-8 hours of entering the T cell zone, the CD8+ 
T cell initiates egress from that structure, ultimately migrating to efferent lymphatics 
(18).  Within the lymphatics, a naïve CD8+ T cell may traffic to another lymphoid organ 
in search for cognate antigen or return to the peripheral blood circulation via the thoracic 
duct. Nevertheless, upon encounter with cognate antigen-MHC I in a SLT, naïve CD8+ T 
cells become activated and being differentiation.   
Whether naïve or recirculating memory CD8+ T cells encounter cognate antigen 
in SLT, these recently activated CD8+ T cells migrate out of the lymphoid tissue as 
recently activated and differentiated cells, move into the efferent lymph, and ultimately 
re-enter the peripheral blood circulation via the thoracic duct (20).  This series of events 
following antigen encounter in SLT allows T cells to migrate to appropriate anatomical 
sites where foreign antigen, infected self cells, or altered self cells reside.   
5		
Chapter 1.2.2 CD8+ T cell activation and cycling 
Activation and expansion of CD8+ T cells is essential for rapid and efficient 
clearance of infected cells and establishment of long-lived memory cells. Our current 
understanding of optimal naïve CD8+ T cell activation and differentiation begins with 
three important external signals (22-24). First, a stable interaction between TCR and 
cognate antigen presented on MHC of the APC, most often dendritic cells, must occur.  
Second, interaction of activating co-stimulatory receptors on T cells, such as CD28 and 
ICOS, with their ligands CD80 and CD86, and ICOSL on the APC (23). These two 
essential engagements, TCR with peptide-MHC and co-stimulatory receptor ligation, 
generate what is known as signal 1 and signal 2, respectively, in the CD8+ T cells and 
initiate activation and memory differentiation programs in these CD8+ T cells.  The last 
signal, signal 3, is required to direct differentiation of recently activated CD8+ T cells 
towards a functional fate. These fates can include long-lived central memory CD8+ T 
cells that lack effector functions or effector CD8+ T cells that maintain the capacity for 
CD8+ T cell effector functions including anti-viral and anti-tumor responses.  Additional 
differentiation fates include regulatory or suppressive fates that are broadly defined as 
anti-inflammatory (i.e. IL-10 and transforming growth factor beta (TGFβ) expressing) or 
stem-cell like that are thought to maintain long-lived T cell memory (25-27). 
In concert, these three signals initiate intracellular signaling cascades that drive T 
cell activation (23, 24, 28).  Broadly speaking, ERK/MAPK, PI3K/AKT and 
Ca2+/calcineurin pathways converge in T cells to orchestrate nuclear localization of 
transcription factors that initiate cell survival, growth, and proliferation, all necessary 
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steps for CD8+ T cell differentiation. Key transcription factors initiated following T cell 
activation include NFκb, NFAT and AP1 among many others (23, 24). In addition, 
commonly produced pro-inflammatory cytokines such as interferon gamma (IFNγ), 
tumor necrosis factor (TNF), and IL-2 can be detected in recently activated T cells (26).  
Production of these pro-inflammatory cytokines is important to promote survival, 
differentiation and expansion of activated T cells (9, 24, 26, 29). 
Surface markers commonly used to identify T cell activation include CD25 the 
high affinity IL-2 receptor, for receiving survival cytokine IL-2, CD69 for tissues 
retention, as well as the expression of HLA-DR on human and non-human primate CD8+ 
T cells, where the function of HLA-DR class II MHC on activated CD8+ T cells is 
unknown. Additionally, PD-1 is upregulated in response to CD8+ T cell activation and 
has functions involved in regulating T cell activation and homeostasis and can therefore 
serve as a marker of T cell activation (30).  
Importantly, following initiation of this activated T cell program T cells 
proliferate to establish a sufficient repertoire of antigen specific T cells and subsequently 
populate the effector and memory repertoire. The expression of Ki67, a surfactant 
involved in chromatin decondensation, is commonly used as an indicator of entry into 
cell cycling or recent completion of cycling (31).   
Chapter 1.2.3 Regulation of activation 
Although activation is a critical state for generating CD8+ T cells that can 
exercise functional capabilities, regulation of T cell activation is critical as it is important 
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to prevent chronic activation and inflammation in the host. Chronic immune activation 
and inflammation can lead to pathology, tissue damage or death of the organism (28, 32-
37). For example, during HIV/SIV infection, persistence of high levels of immune 
activation in treatment naïve hosts results in extensive, irreversible fibrosis of SLT even 
during early chronic infection.  Not surprisingly, chronic immune activation increases the 
risk of developing cardiovascular disease and deposition of atherosclerotic plaques (33, 
38). In addition, regulation of T cell activation and cycling is important to prevent 
excessive proliferation of activated T cells that otherwise may evolve into hematological 
malignancies (39, 40).  
In an effort to mitigate deleterious consequences of T cell activation, many layers 
of regulation, including the recently focused on group of inhibitory receptors are present 
following T cell activation (34).  The inhibitory receptors involved in driving regulation 
include CLTA-4, PD-1, Lag-2, 2B4, CD160, Tim3, and TIGIT among others (34).  
Inhibitory receptors binding to ligands converge to modulate and dampen T cell 
activation.  In cases of chronic viral infection and cancer, the generation of exhausted 
CD8+ T cells, consequential of persistent high levels of antigen stimulation and pro-
inflammatory cytokines, is unfavorable for clearance of target cells but paradoxically 
necessary for the survival of the host (41).  
Despite some undesirable caveats of T cell activation during infection or cancer, 
the ability to establish long-lived memory requires mitigation of T cell activation.  
Moreover, the immune system depends on proper regulation of T cell activation for full 
execution of immunological and adaptive functions. 
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Chapter 1.2.4 CD8+ T cells differentiation 
CD8+ T cell differentiation following recent activation includes memory and 
effector fates. As in many examples of cellular and organ system development, how T 
cells make fate decisions to become effector or memory CD8+ T cells has not been 
worked out entirely and at some level appears stochastic. However, we do know that 
differentiation of effector and memory cells is influenced by inflammation via cytokine 
signaling, otherwise known as signal 3 (Chapter 1.2.2) (9, 42). For example, memory 
versus effector fate decision has been shown to be dependent on the pro-inflammatory 
cytokine milieu determined by the innate response to the encountered pathogen or 
altered-self cell (42). Pro-inflammatory signals released by innate immune, fibroblast or 
directly infected cells are essential for decoding and relaying the location, and quantity of 
antigen to CD8+ T cell effector cells for efficient clearance of the antigen (26, 43, 44). 
Despite a lack of an agreed upon model of memory differentiation, it is certain that 
effector CD8+ T cells expand to high levels immediately following encounter with 
cognate antigen, either during primary or secondary responses, and memory responses 
expand following clearance of the antigen and source. 
Chapter 1.2.5 Effector CD8+ T cells 
Following antigen exposure and T cell activation, a pool of effector CD8+ T cells 
specific for the ensuing target antigen is heavily seeded in the circulation and 
subsequently in infected tissues. The primary designation of effector CD8+ T cells is to 
execute cell-mediated effector responses and clear target cells as rapidly as possible or to 
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inhibit viral replication. Several effector mechanisms CD8+ T cells use have been 
identified. These functions fall into two major categories; cytolytic and non-cytolytic 
functions. Cytolytic functions induce cell death of the target cell, whereas non-cytolytic 
functions induce suppressive mechanism such as inhibition of proliferation, viral 
replication, infection, migration or survival of pathogens (4-6). Nevertheless, CD8+ T 
cells are the major contributing force to anti-viral and anti-tumor effector responses by 
the adaptive immune system.  
Several differences in effector CD8+ T cell phenotyping exist between human and 
rhesus macaque (RM) primarily due to availability of macaque cross-reactive 
immunophenotyping antibodies as opposed to true differences in antigen expression on 
equivalent memory CD8+ T cell subset seen between mice and humans. RM effector 
CD8+ T cells are characterized phenotypically by the loss in expression of CCR7, 
CD62L and CD28, and the gain in expression of CD95 (45, 46) (Figure 1-3). In humans, 
effector CD8+ T cells are commonly characterized by loss of CCR7, CD62L and CD27 
but do not gain the expression of CD45RO (46). The loss in expression of trafficking 
receptors CCR7 and CD62L facilitates exit from SLT and migration to sites of infection 
(19, 20). The loss of CD28 co-stimulatory receptor is thought to regulate stimulation and 
prevent alternate differentiation fates and the acquisition of CD95, or FAS, to induce Fas 
mediated cell death on target cells.  
The transcriptional network that establishes effector differentiated CD8+ T cells 
in RM and humans is similarly defined. Differentiation of naïve or memory CD8+ T cells 
into terminally differentiated effectors or effector memory CD8+ T cells includes high 
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expression levels of the transcription factors T-bet, Blimp1, and Id2 where in the absence 
of either of these factors robust effector functions and clearance of viral infections is 
severely impaired (28, 47-56). Eomesodermin (Eomes) has been identified in effector 
CD8+ T cells but is not exclusively expressed in terminal effectors and is detectable in 
central memory CD8+ T cells (47, 49, 54-58).  It has also been proposed that Runx3 is 
involved in early effector differentiation and essential for early cytolytic functions (59, 
60).  At the same time, repression of transcription factors Bcl-6, TCF1, and Id3 is 
required for full effector differentiation and functions (56, 61-63). 
Effectors cells are often referred to as terminal effectors cell as they undergo full 
attrition and cell death following clearance of antigen. While this attrition occurs, effector 
memory and long-lived central memory cells persist with specificity for the same target 
antigen, where central memory CD8+ T cells are believe to persists for a longer duration 
than effector memory CD8+ T cells. Currently, the exact sequences that lead to central 
memory differentiation are not clear. For example, whether central memory CD8+ T cells 
are seeded during the initial exposure to infection and primary activation, or whether they 
are differentiated and seeded subsequent to clearance of target antigen or infection 
remains undefined (53). Nevertheless, what is clear is the establishment of a long-lived 
repertoire of antigen specific CD8+ T cells (central memory) that retain the ability to 
differentiate into effector CD8+ T cells upon re-exposure to antigen.  
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Chapter 1.2.6 Establishing long-lived CD8+ T cell memory  
The memory T cell compartment is composed of effector memory, transitional 
memory and central memory subsets.  Each serves to retain immunological recognition 
and response to foreign antigen following initial exposure as well as functional 
responsiveness during re-exposure. Memory CD8+ T cells have the potential to 
differentiate into effector CD8+ T cells during recall responses. 
The effector memory subset of CD8+ T cells retain some machinery immediately 
available to mediate effector functions or differentiate into terminal effector cells. This 
machinery includes perforin and granzyme B expression and transcriptional profiles 
expressing T-bet, Blimp1 and Id2 to rapidly acquire full effector functions upon re-
exposure and even during primary exposure (64). At the same time, expression of Bcl6, 
ID3 and TCF1 are actively repressed to inhibit central memory cell differentiation.  The 
longevity of effector memory responses however, is thought to be less than central 
memory or transitional memory cells. Effector memory CD8+ T cells in RM are 
phenotypically identified by CD95 expression and the absence of CCR7, CD62L and 
CD28, which at the same time include terminal effectors (45) (Figure 1-3). In humans, 
effector memory CD8+ T cells most critically are defined by the absence of CCR7, 
CD62L and CD27, and the expression of CD45RO (46). 
 Central memory CD8+ T cells passively and actively survey the host for re-
exposure to antigen (20, 21, 65). True central memory CD8+ T cells are thought to have 
the greatest longevity and retained ability to give rise to effector and effector memory T 
cells upon re-exposure for many years following primary exposure. However, this 
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thought has more recently been challenged following the characterization of stem cell 
memory CD8+ T cells (25). Central memory CD8+ T cells are less immunologically and 
metabolically active than effector responses and depend on cytokines IL-7 and IL-15 as 
opposed to dependence on cognate antigen for their survival as with effector CD8+ T 
cells (26, 66).  Dependence on homeostatic cytokine signaling affords the possibility of 
central memory T cells to persist in the absence of antigen. CD8+ central memory T cells 
lack the machinery to carry out effector functions, but maintain the ability to produce 
cytokine or inflammatory cytokine production upon exposure to cognate antigen. Thus, 
stimulation and production of cytokines is often used as a measure of memory persistence 
(10). CD8+ central memory T cells are often identified in RM by the co-expression of 
CD28 and CD95, along with CCR7 expression, where CCR7 is important for T cell 
migration to SLT where these cells can survey for re-exposure to cognate antigen (45).  
In humans, central memory T cells are often identified by CD45RO, CCR7, CD62L and 
CD27 expression (46).  In both humans and RM, central memory T cells maintain a 
similar transcriptional profile including sustained Eomes expression, Fox01, Bcl-6, Tcf1, 
Bach2 and the absence of high levels of T-bet and Blimp1 (9, 49, 53, 67-69).  
Transitional memory CD8+ T cells appear as an intermediate population between 
central and effector memory differentiation CD8+ T cells (69). However, current 
proposed models of memory differentiation have not been able to confirm whether or in 
which direction, transitional memory CD8+ T cells move and which memory 
compartment they sustain if any. In RM, transitional memory CD8+ T cells are identified 
by expression of CD28 and CD95 in the absence of CCR7, whereas in humans 
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expression of CD45RO and CD27, in the absence of CCR7 and CD62L phenotype the 
transitional memory subset (45, 46).  
Chapter 1.2.7 Memory CD8+ T cell recirculation, distribution and tissue-resident 
memory CD8+ T cells 
As discussed previously, central memory T cells survey the host continuously for 
a re-encounter with cognate antigen (Figure 1-1). As such, central memory T cells 
maintain the expression of receptors that respond to chemokine gradients for recruitment 
to SLT (19-21).  Thus, many central memory T cells can be found in SLT during 
homeostasis (21, 70).  However, central memory T cells compose a small fraction of 
memory CD8+ T cell in the peripheral blood as compared to the effector memory and 
naïve composition (70). These data suggest that central memory T cells actively migrate 
throughout the circulatory system and SLT providing full surveillance of the host for 
timely responses upon re-exposure.   
A more recently described and highly attractive population of memory CD8+ T 
cells called tissue resident memory cells (Trm) are tissue residing antigen experienced 
memory cells that provide rapid antigen-specific defense upon re-exposure (71-76). 
Initial characterization of Trms following antigen priming via vaccination or pathogen 
challenge was characterized in epithelial layers of skin and gastrointestinal tract of 
challenged mice (77).  More recently, Trms have been described to take residence in 
primary and secondary lymphoid tissues, such as thymus and lymph nodes (71, 73, 74). 
These memory CD8+ T cells have been identified based on the expression of retention 
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molecules CD103 and CD69 as well as adhesion molecules such as alpha-4 beta-7 and 
other integrins (72, 75, 76). Although, there has been no single immunophenotype that 
describes the Trm subset of CD8+ T cells that is constitutively expressed irrespective of 
tissue residence. Rather, the anatomical residence where Trms are located appears to 
determine the phenotypic profile of these cells. The gene expression profile of Trms from 
various anatomical compartments, primarily analyzed in mice, includes effector 
molecules (ie. granzyme B) with a partial transcriptional profile of effector memory 
CD8+ T cells. 
A key feature of Trms includes limited migration and trafficking. Studies using 
intra animal anatomically distinct flanks, as well as parabiotic mice, determined that 
Trms do not re-circulate but instead take up persistent residence at the site of antigen 
encounter (74, 77). More recently, it has been described that upon re-exposure, Trms seed 
effector CD8+ T cells at the primary exposure site thus confirming their role as rapid 
responder cells (78). 
This thesis addresses the distribution of SIV-specific CD8+ T cells in anatomical 
compartments harboring viral reservoir during the earliest phase of SIV infection 
and during the transition to chronic phase of the infection. 
Chapter 1.3 CD8+ T cell effector functions 
The importance of CD8+ T cell effector function in clearing pathogen infected or 
cancerous self-cells is inarguable. CD8+ T cells use various pathways to mediate cell-
mediated effector responses including contact dependent and contact independent 
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mechanisms that are necessary to execute target cell death or anti-viral immunity (Figure 
1-2).  
Through primary immunodeficiencies identified in humans, we have 
characterized several components of CD8+ T cell effector functions that are indispensible 
for clearance of frequently encountered bacteria, viruses and fungi ubiquitous in our 
surrounding (79). Additionally, we have seen the importance of T cells in mediating 
elimination of cancerous self-cells. This has been highlighted in recent years with 
increasing numbers of solid organ transplantation, where normal post-transplantation 
protocols include long-term T cell immunosuppression that often lead to the generation of 
B cell lymphomas. Similarly, during progressive HIV infection, prior to the advent of 
antiretroviral therapy, most patients developed the severely immune compromised state 
of acquired immunodeficiency syndrome (AIDS) that frequently co-presented with 
lymphomas and sarcomas consequential of CD4+ T cell depletion and full loss of help 
for naïve CD8+ T cell activation.  
More directly, studies using murine model systems including genetic depletion by 
germline knockout, lox-cre inducible deletion, or more recently crisper cas-9 gene 
modification, have parsed out the importance of individual and combinatorial CD8+ T 
cell effector functions (48, 80). Despite differences between humans, non-human 
primates and mice, murine model systems have paved many avenues for better 
understanding human CD8+ T cell biology and methods for improving and modifying 
effector CD8+ T cell functions in vivo.  
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Chapter 1.3.1 Granule-mediated cytolysis 
The most studied and well-understood pathway of cell-cell contact dependent 
induction of target cell killing is granule-mediated cytolysis. This mechanism is rapid and 
target cell directed using antigen-MHC complex recognition specificity, and generally 
sustained for serial killing capacity.  There are two critical components to granule-
mediated cytolysis including a pore forming component, typically perforin, as well as a 
protease that includes several granzyme family members. Both factors are necessary to 
mediate the induction of apoptosis in target cells that signals through caspase dependent 
and independent routes (4). As mentioned, the induction of granule-mediated cytolysis is 
rapid and is known to be critical for clearance and control of lymphocytic 
choriomeningitis virus (LCMV), toxoplasma, vesicular stomatitis virus and listeria 
infections in mice (4, 81). In the absence of granule-mediated cytolytic factors, even 
single component deficiencies in mice, uncontrollable pathogen burden and even death of 
infected mice often occurs (81, 82). Per these studies, it has been determined that both 
factors together are necessary for successful granule-mediated cytolysis. The 
transcriptional program that drives cytolytic effector responses is discussed below in 
Chapter 1.4. Recently, the importance of cytolytic effector mechanisms has been 
discussed in the context of human chronic viral infections including HIV, HCV, HBV 
and EBV (83-87). Infected subjects, who naturally control these viral infections without 
medical intervention, maintain persistent elevated levels of granzymes and perforin over 
those with progressive disease. As such, many studies in chronic viral infection and 
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cancer have focused on understanding the precise evolution of CD8+ T cell effector 
responses that function using granule-mediated cytolysis.   
This thesis addresses the evolution of perforin and granzyme B cytolytic CD8+ T 
cells responses in various anatomical compartments during early SIV infection in 
RM. 
Chapter 1.3.2 Fas-Fas ligand induced cytolysis 
Contact dependent CD8+ T cell effector functions include CD95-CD95L or Fas-
FasL engagement. This ligation and downstream signaling can induce target cell death 
through caspase-dependant and independent mechanisms (4, 88). Not only has Fas-FasL 
signaling been noted as a critical mechanism in clearing altered-self cells, such as 
cancerous or infected, it has also been shown to have critical functions in immune 
homeostasis and modulation of autoreactive cells (88, 89). Most notably, in the lpr, Fas-
deficient mouse, high levels of lymphocyte proliferation and auto antibodies develop 
(90).  
Chapter 1.3.3 Tumor necrosis factor induced cytolysis 
In addition to serving as a cytokine for anti-viral alarm and pro-inflammatory 
response by innate and adaptive immune cells, tumor necrosis factor (TNF) is involved in 
induction of apoptosis in virally infected and cancerous cells (91). TNF is one of the 
earliest cytokines produced by memory CD8+ T cells upon primary and recall responses 
following exposure to cognate antigen. 
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Chapter 1.3.4 Non-cytolytic effector functions  
Non-cytolytic or non-apoptotic CD8+ T cell effector mechanisms function 
through release of anti-viral factors, including beta defensins and an unclassified cell 
anti-viral factor (CAF) (8, 80, 92). Beta defensins include Mip1α/β as well as RANTES.  
These factors have been identified to inhibit HIV/SIV viral entry via competition for 
CCR5 HIV/SIV co-receptor binding and therefore do not induce cytolytic effects on 
infected cells (6). On the other hand, CAF released from CD8+ T cells is known to be 
more directly involved in control of HIV/SIV replication in a unique contact independent 
fashion (93, 94). However, the mechanisms that CAF uses to mediate suppression of viral 
replication in virus infected cells awaits further validation. 
The interplay between cytolytic and non-cytolytic CD8+ T cell effector functions 
have been evaluated by many groups and in the context of various pathogenic infections 
and in anti-tumor studies (95).  It remains debated however, the level of contribution each 
of these components makes in driving effector functions in the host at any given time (87, 
96).  For example, during chronic HIV/SIV infection there is evidence that both cytolytic 
and non-cytolytic CD8+ T cell functions may be involved in establishing and maintaining 
control of viremia, however to what extent each contributes is left for further 
investigation (87, 97, 98).   
Chapter 1.4 Transcriptional regulation of CD8+ T cell effector program  
The induction of the effector CD8+ T cell program requires a complex network of 
input signals and translation of those signals to induce expression of the proper 
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transcription factors. Although the evolution of effector CD8+ T cell programming 
continues to unveil layers of transcriptional networks including cooperative regulation 
and opposing repression, the currently understood balance of the necessary network relies 
heavily on a few key transcription factors. The master regulatory factors required for 
establishing the optimal effector program include T-bet, Blimp1 and Id2 (99, 100).  
Genetic deletion or haploinsufficiency of either of these key transcription factors severely 
impairs CD8+ T cell effector differentiation and functions, and consequently results in 
uncontrolled viremia and loss of anti-tumor functions (47-49, 52, 53, 55, 56, 67, 69, 101-
104).  
Several other well characterized transcription factors are known to play a role in 
the effector CD8+ T cell program that function in a context dependent manner and rely 
on the presence of and regulation by master regulatory factors. These include Eomes, 
Runx3 and more recently characterized Zeb2 (49, 53, 60, 102, 105, 106). In addition, the 
more upstream factor Notch has been described in driving effector memory CD8+ T cell 
fate (107, 108). It is important to keep in mind that Notch activation is induced following 
extracellular ligand binding and cleavage for translocation to the nucleus, highlighting 
exogenous regulation of effector functions. Moreover, these transcription factors are 
critical components of the hallmark transcriptional network that has been decoded to 
date, although none appears to be as critical as the master transcription factors discussed 
above. 
While the discussed transcription factors are important for turning on the effector 
memory CD8+ T cell program, there are several factors that must be repressed to drive 
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differentiation and maintenance of effector cell functions. Broadly across cell 
differentiation and development, the phenomenon of active repression of alternate fates 
has repeatedly been described. During effector CD8+ T cell differentiation, active 
repression of transcription factors Bcl-6, ID3, Tcf1 and Foxo1 are in place (62). Bcl-6 is 
known to compete with Blimp1 and Id2 in effector cells, and with T-bet in effector and 
memory T cells (52, 55, 63, 69, 100, 109). Importantly, several studies have characterized 
a master regulatory role for the transcription factor Foxo1 in driving the expression of 
central memory differentiation factors and actively repressing the effector memory 
program (58, 61, 68, 69). Nevertheless, the regulation and maintenance of a unique 
transcriptional profile and network of factors is essential for effector CD8+ T cell 
differentiation and the ultimate desired effector function and in establishing long-lived 
immunological memory. 
This thesis characterizes expression of the transcription factor T-bet in SIV-specific 
CD8+ T cells during acute phase SIV of infection to evaluate proper transcriptional 
regulation of the cytolytic effector program. 
Chapter 1.5 CD8+ T cell function in chronic viral infections 
While CD8+ T cells can recognize an infinite number of antigens and even 
generate a memory response to those antigens for the duration of the life of the host, 
many viruses evade immune detection and/or clearance and subsequently establish 
deleterious chronic infections. Such viral infections include HIV, Hepatitis C and B  
(HCV and HBV, respectively), Epstein-Barr virus (EBV), and HPV driving cutaneous, 
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hematologic, hepatic, and eurogenital and head and neck malignancies (110, 111). The 
inability to clear these viral infections is at least in part due to insufficient function of 
CD8+ T cell effector responses.  
Chapter 1.5.1 Animal models for understanding CD8+ T cells functions during 
chronic viral infections 
Our understanding of the importance of CD8+ T cells in control of viral infection 
has been achieved through the use of various animal models including mice and non-
human primates. Importantly, these models have afforded us the opportunity to identify 
CD8+ T cell correlates of control with deeper rigor than using patient derived T cells 
alone. Studies using the LCMV infection model in mice have done an exceptional job at 
teasing apart the formation of efficient and insufficient effector and memory CD8+ T cell 
responses following exposure to chronic LCMV. In an effort to more closely mirror the 
induction of chronic HIV infection in humans, the SIV infection model in RM has been 
instrumental in identifying the functions and dysfunctions of CD8+ T cells that lead to 
HIV/AIDS and SIV/SAIDS that are similarly applicable in understanding persistence of 
other human chronic viral infections.  
The importance of CD8+ T cells in control of viral infections has been 
demonstrated in their absence by way of antibody-mediated depletion or β2microglobulin 
knockout- MHC Class I deficiency in murine models (112-114). In these CD8+ T cell 
deficient models, viral infections are unmanaged and remain high following initial 
exposure in absence of CD8+ T cells or subsequent to CD8+ T cell depletion during 
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established infection consequently leading to premature disease-mediated pathology, 
progression and ultimately death of the host. Additionally, the induction of viral escape 
mutations to CD8+ T cell recognized epitopes has highlighted the magnitude and success 
of CD8+ T cell immune pressure on virus to select against viral variants expressing those 
recognized epitopes (115-119). Moreover, animal models have provided an invaluable 
tool to define and demonstrate the critical importance of CD8+ T cells in clearing or 
controlling infection.  
With particular interest to this thesis, the use of the RM SIV infection model has 
fostered our understanding of the importance of CD8+ T cell in resolving acute phase 
viremia, or set point viremia. More recently, studies have described the importance of 
maintaining CD8+ T cells within the SLT for containment of virus in lymphoid follicles 
during acute and chronic phases of SIV infection (112, 113, 120-122). Along these lines, 
Cartwirght et al. recently showed the requirement for CD8+ T cells in the full 
suppression of SIV viremia, even under antiretroviral therapy (123). 
This thesis describes work implementing the RM SIV infection model to 
characterize the evolution of CD8+ T cells in critical anatomical compartments 
during acute and progressive SIV infection. 
Chapter 1.5.2 CD8+ T cell correlates of viral control 
The presence of CD8+ T cells alone is insufficient for mediating clearance or 
adequate control of viral infections. CD8+ T cell correlates of viral control begin with 
optimal exposure to cognate antigen via APCs, TCR signaling, co-stimulation and 
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sufficient CD4+ T cell help. Not surprisingly, associations between MHC I alleles and 
the ability to control HIV/SIV infection are well described and are preferentially 
expressed in a population of infected subjects, elite controllers, who maintain control of 
viremia without therapeutic intervention (124, 125). For this reason, it is likely that 
optimal antigen recognition and TCR signaling occur with these particular MHC alleles 
that allow development of the most optimal CD8+ T cell effector responses (126). These 
initial steps are foundational for the induction of the effector memory program where 
high levels of master regulatory factors such as T-bet and Blimp1 are induced and 
maintained throughout the peak of infection until pathogen clearance (47, 85, 121, 127-
129). Early loss of high levels of T-bet are associated with the induction of poor effector 
functions, described as immune exhaustion (47, 128, 130). Equally as important, 
expression of cytolytic factors such as perforin and granzymes by CD8+ T cells are 
essential for mediating clearance of target cells and their expression levels correlate with 
viral control and clearance (83, 85, 86, 127, 131, 132). Each of these CD8+ T cell 
correlates of control contributes to establishment and maintenance of functional CD8+ T 
cell memory. 
Chapter 1.5.3 CD8+ T cell exhaustion in chronic viral infection 
Our best understanding and explanation of viral persistence of chronic viral 
infection is the development of progressively dysfunctional CD8+ T cell responses, 
otherwise known as CD8+ T cell exhaustion. We are currently impressed by how early 
during infection CD8+ T cell dysregulation begins, immune exhaustion is established and 
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consequential persistent viral infection is established. In the murine model of chronic 
viral infection with LCMV clone 13, the kinetics of virus-specific CD8+ T cell 
dysregulation has been evaluated and implicated to develop as early as 8 days post 
infection (127, 128). From this model, we have identified and characterized exhausted 
CD8+ T cells by loss in optimal transcriptional regulation by T-bet and Blimp1, and 
progressive acquisition of the inhibitory receptor expression profile most notably of PD-
1, 2B4, CD160, and Lag3 among others (47, 127, 128, 133-138). At the same time, 
exhausted CD8+ T cells progressively lose cytokine polyfunctionality in a hierarchical 
fashion, beginning with IL-2 followed by TNF and lastly IFNγ (137, 139). Importantly, 
these characteristic developments of CD8+ T cells during chronic LCMV infection have 
been nearly directly translatable to the phenomenon of immune exhaustion in humans and 
non-human primates during viral infections and cancer.  
Induction of immune exhaustion during human chronic viral infections has been 
less well characterize due to complications in precisely identifying primary infection and 
time to diagnosis, as well as tissue sample availability in human subjects that is typically 
restricted to peripheral blood, a tissue that may not be an appropriate sample of 
lymphocytes in close proximity to viral reservoir. However, characterization of poorly 
functional virus-specific CD8+ T cells during chronic viral infections in humans has been 
described (83, 85, 86, 130, 132, 140). A recent study from our lab identified acute phase 
dysregulation of T-bet expression in HIV-specific CD8+ T cells following peak HIV 
viremia that persisted into chronic phase of infection and was associated with a loss in 
cytolytic perforin expression as infection progressed (130). Moreover, the consequential 
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induction of CD8+ T cell dysregulation during the acute phase of chronic viral infections 
demands continued attention for improved clinical outcomes. 
Chapter 1.6 HIV/SIV pathogenesis and the immune system 
Infection with HIV in humans or SIV in macaques poses genuinely unique 
challenges to the immune system in the feasibility of managing the virus. Most 
importantly, the CD4+ T helper cells that HIV/SIV infects are a backbone of the adaptive 
immune system (Discussed in Chapter 1.1.2). For example, immunological memory 
functions that are highly dependent on CD4+ T helper cells are progressively lost during 
infection. Moreover, infected hosts do not succumb to the viral infection itself but rather 
the consequential immunopathologies associated with the infection that ultimately 
establish the immune deficient state of AIDS.  
During primary exposure, antiviral responses including high levels of immune 
activation are initiated and persist. In an antiviral effort, massive pro-inflammatory 
responses driven by type I interferons and immune activation are initiated that 
paradoxically feed a detrimental cycle of inflammation and further susceptibility to 
infection. Upon activation, CD4+ T cells express the chemokine receptor CCR5, the 
canonical co-receptor for HIV/SIV viral entry, and become susceptible to infection. In 
most cases of infection, the immune system manages to establish some balance between 
immune activation and viral replication where a viral set point is achieved and viremia is 
maintained at the set point level for a period of time until the immune system fails to 
maintain this balance.  
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Chapter 1.6.1 Loss of CD4+ T cell help impacts new immunological memory 
formation during HIV/SIV infection 
The persistent immune activation and consequential depletion of infected CD4+ T 
helper cells following HIV/SIV infection have cumulative consequences for generating 
new adaptive immune responses. CD4+ T helper cells provide the essential signals for 
selection, programming and expansion of memory T and B cell responses. While the 
availability of helper functions dampen throughout infection, the potential breadth of 
memory CD8+ T and B cell repertoires becomes compromised. This impairment of 
helper functions impacts not only new response to HIV/SIV, but also impacts responses 
to persistent co-infections such as cytomegalovirus virus and EBV, or new encountered 
pathogens and altered-self proteins. For example, patients with chronic HIV infection 
have reduced breadth of memory T and B cells responses to flu virus following flu 
vaccination and increase presentations of cancers driven by EBV, HCV, HBV, human T 
lymphocytic virus-1, and Kaposi’s sarcoma herpes virus (110, 111). Humoral mediated 
responses are known to contribute to the control of HIV/SIV viremia. Therefore, loss of 
helper functions to expand the repertoire of antibodies against HIV/SIV are also likely 
impaired by progressive CD4+ T cell depletion.   
Chapter 1.6.2 Immunopathologies associated with HIV/SIV infection 
While depletion of CD4+ T cells is known to be the most deleterious consequence 
of HIV/SIV infection, additional immunopathologies are irreversibly established even 
following initiation of antiretroviral treatment. Rapid and sustained depletion of CD4+ T 
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cells from the gut mucosa compromises the integrity of the local mucosal barrier and has 
been implicated in fostering chronic immune activation via bacterial translocation from 
the gut lumen to the circulation (141). For undefined reasons that may be associated with 
trafficking, CD4+ T cells are not replenished in the gut mucosa, even during 
antiretroviral treatment (142). Equally as important, massive immune activation triggers 
local deposition of fibrous material at sites of infection including SLT and gut mucosa 
(33, 143). While in most infections this deposition can facilitate containment of the 
pathogen, collagen deposition to lymphoid tissues and gut mucosa exacerbates impaired 
immune memory formation and normal barrier functions of the gut mucosa (144). 
Specifically, deposition of collagen in SLT disrupts the intricate and purposefully 
designed architecture that is essential for orchestrating immune cell localization, contact 
and ultimately formation of lymphoid follicles and germinal centers (144).  
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Chapter 1.7 Figures 
 
Figure 1-1 Classical model of CD8+ T cell memory differentiation and tissue 
distribution following infection 
Encounter of CD8+ T cells with antigen presented on APC in SLT and subsequent CD4+ 
T cell help in activation and memory differentiation prior to egress of the CD8+ T cell 
from lymphoid tissue. High accumulation of effector memory CD8+ T cells occurs 
within the peripheral blood circulation, as compared to central memory and transitional 
memory responses. Effector and effector memory responses reach infected tissue, where 
infected cells are cleared by CD8+ T cell effector functions.  Following clearance of 
infection, tissue resident memory CD8+ T cells can be detected at the sites of cleared 
infection. Central memory responses mediate systemic surveillance of SLT for re-
exposure to antigen by way of high endothelial venules, and peripheral blood circulation. 
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Figure 1-2 CD8+ T cell effector functions 
Cytolytic and non-cytolytic CD8+ T cell effector functions used to reduce viral burden 
during infection.  Cytolytic effector functions deliver cytotoxic granules directly to target 
cells in a contact-dependent manner that are driven via TCR recognition of peptide on 
MHC I. Non-cytolytic functions secrete antiviral factors in a contact-independent manner 
that block viral entry and directly suppress viral replication in infected cells. 
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Figure 1-3 Gating strategy for CD8+ T cell memory subset identification 
A) Identification of CD8+ T cells through fluorescence cytometry staining for antigens 
expressed by CD8+ T cells.  Gating strategy for stained lymphocytes to isolate CD8+ T 
cells and subsequent identification of naïve and memory CD8+ T cell subsets.  
Differential expression of additional antigens of interest can be identified in memory 
CD8+ T cell subsets. B) CD8+ T cell memory subsets in RM are identified by the 
indicated combinatorial staining of CD28, CD95 and CCR7. 
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Chapter 2:  Collapse of cytolytic potential in SIV-specific 
CD8+ T cells during acute SIV infection in Rhesus Macaques  
Chapter 2.1 Abstract 
Poor maintenance of cytotoxic factor expression among HIV-specific CD8+ T 
cells, in part caused by dysregulated expression of the transcription factor T-bet, is 
associated with HIV disease progression. However, the precise evolution and context in 
which CD8+ T cell cytotoxic functions become dysregulated in HIV infection remain 
unclear. Using the RM SIV infection model, we evaluated the kinetics of SIV-specific 
CD8+ T cell cytolytic factor expression in peripheral blood, lymph node (LN), spleen, 
and gut mucosa from early acute infection through chronic infection. We identified rapid 
acquisition of perforin and granzyme B expression in SIV-specific CD8+ T cells in 
blood, SLTs and gut mucosa that collapsed rapidly during the transition to chronic 
infection.  The evolution of this expression profile was linked to low expression of T-bet 
and occurred independent of epitope specificity, viral escape patterns and tissue origin. 
Importantly, during acute infection SIV-specific CD8+ T cells that maintained T-bet 
expression retained the ability to express granzyme B after stimulation, but this 
relationship was lost in chronic infection. Together, these data demonstrate the loss of 
cytolytic machinery in SIV-specific CD8+ T cells in blood and at tissue sites of viral 
reservoir and active replication during the transition from acute to chronic infection.  This 
phenomenon occurs despite persistent high levels of viremia suggesting that an inability 
to maintain properly regulated cytotoxic T cell responses in all tissue sites enables 
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HIV/SIV to avoid immune clearance, establish persistent viral reservoirs in lymphoid 
tissues and gut mucosa, and lead ultimately to immunopathogenesis and death. 
Chapter 2.2 Introduction 
While it is clear that CD8+ T cells are a critical component of the host immune 
response to HIV and SIV control, these cells only rarely fully control virus replication 
(i.e., elite controllers) (145-147). The reasons why CD8+ T cells do not control HIV/SIV 
replication in the majority of infected individuals remain unclear. Seminal work directly 
identifying the importance of CD8+ T cells in partial containment of viremia was 
performed in SIV infected RM, whereby depletion of CD8+ T cells consistently resulted 
in significant increases in viremia and accelerated disease progression (112, 113). In 
addition, in vivo viral evolution studies revealed the emergence of escape mutants for the 
most common immunodominant CD8+ T cell viral epitopes of SIV, thus demonstrating a 
significant level of immune pressure exerted on the virus by CD8+ T cells (116, 118).  
More recently, CD8+ T cell depletion studies in elite controller SIV infected RM 
indicated the requirement of CD8+ T cell persistence in LN and spleen to maintain 
control of plasma viremia and productively infected CD4+ T cells in these tissues (120, 
122).   
Several effector mechanisms have been proposed to explain how CD8+ T cells 
mediate viral control, including cytolytic and non-cytolytic processes (7, 97, 98). 
Granule-mediated cytolysis is a rapid and powerful effector response used by cytotoxic 
CD8+ T lymphocytes (CTL) to clear target cells in an antigen-specific manner (4, 5).  
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This process includes two necessary factors, a pore forming component, perforin, which 
enables entry of a protease, most often granzyme B, to induce programmed cell death 
through both caspase-dependent and caspase-independent induction of apoptosis (4). The 
induction and maintenance of granule-mediated cytolysis, including the expression of 
perforin and granzyme B has been shown to be in part mediated by the transcription 
factor T-bet, where in its absence CD8+ T cell effector functions are significantly 
reduced (47, 48, 85, 102, 130, 148, 149). Previous studies have shown that the 
maintenance of CD8+ T cell killing capacity is a key factor in control of HIV infection, 
as measured by granzyme B and perforin expression and expression levels of T-bet (83, 
85, 86, 131, 132). These studies highlight the relationship of low levels of viremia in HIV 
elite controllers with the presence of robust T-bet controlled CTL killing potential by 
HIV-specific CD8+ T cells that is present through chronic phase of infection. This is 
further supported by a recent study from our group describing the evolution of HIV-
specific CD8+ CTL during acute infection and identified the loss of T-bet and concurrent 
declining perforin expression as key markers of the transition from acute to the chronic 
phase of HIV infection (130). Virus-specific CD8+ T cell non-cytolytic mechanisms 
mediated by β-chemokines, α-defensins, and the unclassified suppressive factor, CAF, 
have been evaluated albeit less extensively than cytolytic mechanisms during HIV/SIV 
infection (6, 93, 94, 150).  Both Mip-1α and α-defensin productions by CD8+ T cells are 
positively correlated with control of HIV viremia in elite controller subjects, although 
their role is likely more involved in blocking receptor binding and subsequent infection 
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(150-152). Nevertheless, these factors are thought to contribute to control of viremia 
without elimination of infected cells (97, 98). 
Secondary lymphoid tissues and gut mucosa are key sites of HIV/SIV replication 
and reservoirs during the acute and chronic phases of infection (153-156). In particular, 
follicular CD4+ T helper cells harbor high levels of integrated provirus and are major 
contributors to both ongoing viral replication and virus rebound observed following 
interruption of antiretroviral therapy (153, 154). Studies detecting virus-specific CD8+ T 
cells from SLT and gut mucosa have been focused primarily on the chronic phase of 
infection with few studies investigating the early acute phase (155, 157-160). As such, it 
remains unclear to what degree virus-specific CD8+ T cells in these compartments 
possess cytolytic function when the reservoir is first seeded and subsequently maintained. 
These studies underscore the need to evaluate virus-specific CD8+ CTL potential in SLT 
and gut mucosa in the earliest detectable responses in acute infection, as well as those 
present during chronic infection. 
In the current study we sought to address these issues through sequential necropsy 
conducted during the acute phase of infection in SIV infected macaques to longitudinally 
dissect the evolution of cytolytic CD8+ T cell function in blood and at relevant sites of 
viral replication, including SLT and gut. To this end, we infected Mamu A*01-positive 
RM with SIVmac251 and longitudinally monitored the CD8+ T cell responses to two 
immunodominant epitopes, Tat-TL8 and Gag-CM9, for their acquisition and modulation 
of cytolytic factors granzyme B and perforin in blood, spleen, LN and gut mucosa 
through the earliest stages of acute infection and up to chronic infection. We found that 
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the initial high expression of cytolytic factors was remarkably short-lived, and collapsed 
rapidly during late acute infection in nearly all animals. This phenomenon resulted in low 
levels of cytolytic SIV-specific CD8+ T cell responses during the chronic phase of 
infection despite high plasma viremia. Notably, SIV-specific CD8+ T cells in LN 
consistently expressed lower levels of perforin, and granzyme B as well as T-bet 
compared to their peripheral blood counterparts. These findings demonstrate the rapid 
collapse of a dominant cytolytic profile among SIV-specific CD8+ T cells during acute 
SIV infection in all tissue compartments, most importantly in SLT where active seeding 
of SIV reservoir and viral replication is initiated and persists during chronic infection. 
Chapter 2.3 Results 
Induction and resolution of cytolytic SIV-specific CD8+ T cell responses during 
acute SIV infection 
To define the acute kinetics of the CD8+ T cell response in SIV infection, we 
infected n=18 RM with 500TCID50 SIVmac251 iv and performed a timed tissue collection 
and necropsy protocol through chronic infection. We collected blood, spleen, mesenteric 
lymph nodes (mLN), superficial lymph nodes (sLN), and rectal biopsies (RB) at the 
indicated time points pre- and post-infection (Figure 2-1a and Figure 2-2a). We infected 
all animals with a high dose of SIVmac251 virus in order to synchronize the infection and 
peak viremia. As shown in Figure 2-2b, the kinetics of viremia were uniform and 
reproducible in all animals. As expected, viremia in these animals peaked between 10 and 
13dpi (Range: 1.5e7 - 1.06e8), and high viral loads persisted until necropsy.  No animals 
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showed signs of controlled viremia during the transition from acute to chronic phase of 
infection.  As expected, during acute infection, absolute CD4+ T cells counts decreased 
rapidly and remained low in all animals (Figure 2-2c), and the percentage of CD4+ T 
cells in the gut mucosa declined precipitously within the first 5dpi, and remained very 
low in all animals (Figure 2-2d)(161). 
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Figure 2-1 Evolution of CTL in peripheral blood during acute SIV infection 
A) Experimental design including SIV infection, tissue and blood sample collection (TC), 
and necropsy (Nec) time points. B) Flow cytometry plots of Tat-TL8 and Gag-CM9 
Mamu A*01 tetramer staining in CD8+ T cells at pre-infection, acute, and chronic 
infection from a representative animal. Frequencies of single positive tetramer+ events 
are shown. C) The frequency of TL8 and CM9 tetramer+ SIV-specific CD8+ T cells in 
peripheral blood CD8+ T cells throughout infection. D) Flow cytometry plots of perforin 
and granzyme B expression in TL8 and CM9 tetramer+ SIV-specific CD8+ T cells (TL8 
tetramer+ in red, and CM9 tetramer+ in blue) overlaid on total CD8+ T cells (black) at 
pre-infection, 13dpi, and 90dpi from representative animals. Frequencies of gated 
populations are shown of TL8 or CM9 tetramer+ cells. E) The frequency of perforin and 
granzyme B (Perf+GrzB+) co-expression among TL8 or CM9 tetramer+ SIV-specific 
CD8+ T cells throughout infection. F) The median fluorescence intensity (MFI) of 
perforin and granzyme B in Perf+GrzB+, tetramer+ SIV-specific CD8+ T cells 
throughout infection. Lines connecting data points represent longitudinally collected data 
from individual animals. 
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Figure 2-2 Established infection and sample collection schedule 
A) Detailed tissue collection schedule including the number of unique samples collected 
at each indicated time point. B) SIV blood plasma viral loads (RNA copies/mL) at the 
indicated time points post-infection from each animal. Lines connecting data points 
reflect longitudinal monitoring of individual animals. C) Absolute CD4+ T cell counts 
per mL of whole blood at the indicated time points from individual animals. Mean ± SD 
of data collected at each time point is plotted as a line along with individual data points. 
D) CD4+ T cell counts as a proportion of total CD3+ T lymphocytes from rectal biopsies 
(RB) at the indicated time points from individual animals. Mean ± SD of data collected at 
each time point is plotted as a line along with individual data points. 
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To assess the induction of cytolytic SIV-specific CD8+ T cell responses, we first 
evaluated the responses to the immunodominant Mamu A*01 restricted epitopes Tat-TL8 
and Gag-CM9 in peripheral blood.  As shown in Figure 2-1b and Figure 2-1c, CD8+ T 
cells specific for TL8 or CM9 epitopes peaked at 13dpi, followed by contraction into the 
chronic phase of infection as previously been described (116). We next evaluated the 
expression of the cytolytic proteins perforin and granzyme B by SIV-specific CD8+ T 
cells.  We found high co-expression of both molecules in Tat-TL8 and Gag-CM9 specific 
CD8+ T cells in blood that peaked at 13dpi, as shown in Figure 2-1d and Figure 2-1e. 
This cytolytic profile was short-lived however, with less than 50% on average of SIV-
specific CD8+ T cells maintaining perforin and granzyme B co-expression beyond 21dpi. 
The collapse in co-expression of perforin and granzyme B occurred independent of 
epitope specificity as seen in both TL8 and CM9-specific responses (Figure 2-1e). 
Perforin and granzyme B expression on a per-cell basis peaked at 13dpi of the acute 
phase and similarly decreased as animals progressed into chronic infection (Figure 2-1f).  
Previous studies documented the rapid and complete escape of the Tat-TL8 
epitope (TTPESANL) during acute infection (116). We therefore sought to confirm this 
finding as it relates to potential pressure mediated by cytolytic SIV-specific CD8+ T 
cells.  Escape of the Tat-TL8 epitope, present in more than 50% of SIVmac251 inoculum 
virus (Figure 2-3a), occurred during the peak cytolytic TL8-specific response as seen in 
Figure 2-3b. However, the Gag-CM9 epitope did not escape despite similar CD8+ T cell 
mediate cytotoxic pressure, likely due to fitness constraints on this epitope as discussed 
previously (Figure 2-3b) (115). Together these data show that the initial circulating CD8+ 
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T cell responses to SIV infection have high expression of cytolytic molecules that is 
rapidly lost as infection transitions into the chronic phase. 
Rapid loss of cytolytic CD8+ T cells from secondary lymphoid tissues 
To assess the evolution of cytolytic SIV-specific CD8+ T cells at relevant sites of 
viral replication and reservoir, we next examined Tat-TL8 and Gag-CM9 specific CD8+ 
T cell responses in LN, spleen and gut mucosa tissue throughout acute infection. Tat-TL8 
and Gag-CM9-specific CD8+ T cell responses were readily detectable in LN, spleen and 
gut mucosa as previously described (Figure 2-4) (162, 163), peaking at 13dpi in all 
measured tissues, and underwent contraction in all tissues while SIV infection transitions 
into its chronic phase (Figure 2-5a).  
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Figure 2-3 Sequence evolution of Tat-TL8 and Gag-CM9 epitopes 
A) Amino acid sequences of the six most frequently represented Tat-TL8 and Gag-CM9 
epitope sequence variants within SIVmac251 stock inoculum virus. Canonical Tat-TL8 
epitope sequence is highlighted in red, and Gag-CM9 epitope sequence in blue. B) 
Frequencies of canonical TL8 and CM9 epitope sequences in plasma virus throughout 
infection until necropsy at 90dpi from two representative animals.  Dashed line indicates 
the frequency of canonical TL8 or CM9 epitope detected in inoculum viral stock as 
shown in A. 
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Figure 2-4 SIV-specific responses are detected in SLT and gut mucosa by Mamu 
A*01 tetramer staining 
Flow cytometry plots of Mamu A*01 Tat-TL8 and Gag-CM9 tetramer staining in sLN, 
mLN, spleen and RB at the indicated time points from representative animals. 
Frequencies of gated events are shown.  
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Figure 2-5 Evolution of CTL in blood, SLT and gut mucosa during acute SIV 
infection 
A) The frequencies of TL8 and CM9 tetramer+ SIV-specific CD8+ T cells among CD8+ 
T cells in mLN, sLN, spleen, gut mucosa and blood at the indicated time points. B) Flow 
cytometry plots of perforin and granzyme B expression in TL8 and CM9 tetramer+ SIV-
specific CD8+ T cells (TL8 tetramer+ in red, and CM9 tetramer+ in blue) overlaid on 
total CD8+ T cells (black) in blood, sLN, mLN and spleen at pre- infection, 13dpi, and 
90dpi from representative animals. Frequencies of gated populations are shown of TL8 or 
CM9 tetramer+ cells. C) The frequencies of Perf+GrzB+ co-expression in TL8 and CM9 
tetramer+ SIV-specific CD8+ T cells from blood, sLN, mLN and spleen at the indicated 
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Figure 2-5 continued: time points throughout infection; Linear regression ANOVA of 
samples collected between 13dpi and 90dpi. D) Kinetics of perforin median fluorescence 
intensity (MFI) in Perf+GrzB+ TL8 and CM9 tetramer+ SIV-specific CD8+ T cells at the 
indicated time points throughout infection; Linear regression ANOVA of samples 
collected between 13dpi and 90dpi. E) Perforin MFI in Perf+GrzB+ tetramer+ cells in 
sLN and blood at 13dpi or 90dpi; Paired, one-tailed Student’s t-test; 13dpi (n=12 pairs) or 
90dpi (n=3 pairs). Lines connecting data points represent longitudinally collected data 
from sLN and blood of individual animals. * p<0.05 ,  ** p<0.01. No significant 
differences “ns”. 
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Co-expression of perforin and granzyme B was detectable in SIV-specific CD8+ 
T cells in sLN, mLN, and spleen (Fig2-5b) and peaked at 13dpi in all measured tissues 
(Fig2-5c). SIV-specific CD8+ T cells in gut mucosa also showed very high granzyme B 
expression at peak viremia in nearly all animals (perforin not measured; Fig2-6a and 2-
6b). However, following peak responses, we observed a rapid loss of perforin and 
granzyme B co-expression within TL8 and CM9-specific CD8+ T cells in 8 out of 9 
animals by 41dpi, shown in Fig2-5c. We also observed declining granzyme B expression 
in SIV-specific CD8+ T cells in gut mucosa as animals transitioned to chronic infection 
(Fig2-6b). 
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Figure 2-6 Granzyme B and T-bet expression are detectable in SIV-specific CD8+ T 
cells from gut mucosa during acute SIV infection 
A) Flow cytometry plots of granzyme B and T-bet expression in TL8 and CM9-specific 
CD8+ T cells (Tat-TL8 tetramer+ CD8+ T cells in red and Gag-CM9 tetramer+ responses 
blue) in total CD8+ T cells (black) from RB samples pre-infection, at 13dpi, and 41dpi 
(late acute) from a representative animal. Frequencies of gated events among tetramer+ 
events are shown. B) Kinetics of granzyme B expression in tetramer+ SIV-specific CD8+ 
T cells from RB throughout acute infection. Lines connecting data points represent 
longitudinally collected data from individual animals. 
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We next performed a quantitative analysis of the expression levels of perforin and 
granzyme B by median fluorescence intensity (MFI) in the subset of SIV-specific CD8+ 
T cells co-expressing perforin and granzyme B (Figure 2-5d, and Figure 2-7). Similar to 
blood (Figure 2-1f), perforin MFI peaked at 13dpi in SIV-specific CD8+ T cells in sLN 
but showed limited expression throughout infection in mLN and spleen (Figure 2-5d).  
Perforin expression was reduced in SIV-specific CD8+ T cells from sLN compared to 
blood at peak response and in TL8-specific CD8+ T cells during chronic infection 
(Figure 2-5e).  Lower perforin expression levels were detected in CM9-specific CD8+ T 
cells in 2 out of 3 animals at chronic infection. Granzyme B within SIV-specific CD8+ T 
cells largely mirrored the expression level of perforin over time, peaking at 13dpi 
followed by a decline in expression levels during the transition to chronic infection  
(Figure 2-7).  However, unlike perforin expression, we did not detect a significant 
difference in granzyme B expression levels between blood and matched sLN during acute 
or chronic phase of infection (data not shown). Collectively, these data indicate short-
lived cytolytic profiles in SIV-specific CD8+ T cell responses from the blood, SLT and 
gut mucosa during acute infection.  
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Figure 2-7 Kinetics of granzyme B MFI in cytolytic tetramer+ SIV-specific CD8+ T 
cells during acute infection 
Median fluorescence intensity (MFI) of granzyme B in Perf+GrzB+ TL8 and CM9 
Tetramer+ SIV-specific CD8+ T cells in blood, sLN, mLN, and spleen at the indicated 
throughout infection. Linear regression ANOVA for samples collected between 13dpi 
and 90dpi. Lines connecting data points represent longitudinally collected data from sLN 
and blood of individual animals. No significant differences “ns”.  
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Progressive loss of T-bet expression within SIV-specific CD8+ T cells in acute SIV 
infection  
To define potential mechanisms underlying the loss of cytolytic molecule 
expression, we assessed T-bet expression in tetramer+ SIV-specific CD8+ T cells from 
acute through chronic infection. T-bet was initially expressed by a subset of SIV-specific 
CD8+ T cells in blood, LN, and spleen (Figure 2-8a) and gut mucosa (Figure 2-6a) 
during acute infection. T-bet expression in SIV-specific CD8+ T cells peaked at 13dpi in 
all tissues except the spleen, where peak T-bet expression was more varied (Figure 2-8b). 
Subsequent to peak expression, T-bet expression in TL8-specific CD8+ T cells in LN and 
blood declined precipitously following peak viremia, in a similar fashion as cytolytic 
molecules in SIV-specific CD8+ T cells declined (Figure 2-5c). Similar, though not as 
dramatic, losses of T-bet were also observed in CM9-specific CD8+ T cells following 
peak viremia. We also compared the proportion of T-bet+ SIV-specific CD8+ T cell 
responses between sLN and blood, and found no significant difference at 13dpi or 90dpi 
(data not shown). 
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Figure 2-8 Kinetics of T-bet expression in SIV-specific CTL during acute SIV 
infection 
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Figure 2-8 continued: A) Flow cytometry plots of T-bet expression in TL8 and CM9 
tetramer+ SIV-specific CD8+ T cells (TL8 tetramer+ in red, and CM9 tetramer+ in blue) 
overlaid on total CD8+ T cells (black) in blood, sLN, mLN, and spleen at the indicated 
time points from representative animals. Frequencies of T-bet+ tetramer+ events are 
shown. B) The frequencies of T-bet expression among tetramer+ SIV-specific CD8+ T 
cells in blood, sLN, mLN, spleen and gut mucosa at the indicated time points. C) 
Frequencies of T-bet expression in cytolytic (Perf+GrzB+) SIV-specific CD8+ T cells in 
blood, sLN, mLN and spleen throughout infection. Linear regression ANOVA for 
samples collected between 13dpi and 90dpi. Lines connecting data points represent 
longitudinally collected data from sLN and blood of individual animals. No significant 
differences “ns”. 
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We further examined T-bet expression within SIV-specific CD8+ T cells that co-
expressed perforin and granzyme B. T-bet expression was higher in Perf+GrzB+ SIV-
specific CD8+ T cells in all sites during the acute period except in spleen, where T-bet 
expression varied (Figure 2-8c). Following the acute period, T-bet expression within 
Perf+GrzB+ SIV-specific CD8+ T cells declined as infection progressed, with the 
strongest effect occurring in TL8-specific responses. At 90dpi, similarly low levels of T-
bet were detected between the different antigen specificities and tissues examined. 
Together these data show that SIV-specific CD8+ T cells rapidly lose expression of the 
master transcription factor T-bet that is likely required to sustain optimal cytolytic 
responses within CD8+ T cells during the course of infection.  
Partial loss of the cytolytic profile in responding SIV-specific CD8+ T cells following 
acute SIV infection  
We next assessed how SIV-specific CD8+ T cells capable of responding to 
stimulation with SIV peptides changed over time, and whether these cells expressed 
granzyme B and T-bet. SIV-specific CD8+ T cell functional responses to Tat-TL8 or 
Gag-CM9 peptides peaked between 13 and 20dpi in SLT and blood of most animals as 
shown in Figure 2-9, similar to the kinetics of Mamu A*01 tetramer binding (Figure 
2-5a), then subsequently declined in most animals as infection progressed. One animal 
maintained elevated frequencies of CM9- specific functional CD8+ T cell responses up 
until necropsy at 90dpi. 
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Granzyme B was highly expressed in functional SIV-specific CD8+ T cells 
peaking between 13 and 20dpi in LN, spleen and blood, as shown in Figure 2-10a and 
Figure 2-10b, similar to granzyme B expression kinetics within Perf+GrzB+ tetramer+ 
SIV-specific CD8+ T cells (Figure 2-5c and 2-7). Detection of perforin expression was 
not performed in CD8+ T cells following SIV peptide stimulation due to lack of 
appropriate reagents to detect newly upregulated perforin following stimulation. 
Granzyme B expression in responding SIV-specific CD8+ T cells was 2-fold higher in 
blood compared to matched sLN during acute infection (Figure 2-10c). Collectively, 
these data indicate that responding subsets of SIV-specific CD8+ T cells display rapid 
loss of cytolytic protein expression similar to the total SIV-specific CD8+ T cell 
population as infection progresses.  
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Figure 2-9 Functional SIV-specific CD8+ T cell responses throughout infection 
Frequencies of Tat-TL8 and Gag-CM9 functional CD8+ T cell responses in total CD8+ T 
cells following in vitro stimulation from blood, sLN, mLN and spleen at the indicated 
time points 
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Figure 2-10 Functional SIV-specific CD8+ T cell responses lose cytolytic profiles 
throughout acute infection 
A) Flow cytometry plots of granzyme B and T-bet expression in TL8 and CM9 functional 
(CD107a+ and/or IFNγ+ and/or TNF+) SIV-specific CD8+ T cells (TL8 responder in red, 
and CM9 responder in blue) overlaid on total CD8+ T cells (black) in blood, sLN, mLN 
and spleen at the indicated time points from representative animals. B and D) Kinetics of 
granzyme B (B) and T-bet (D) expression in functional TL8 and CM9-specific CD8+ T 
cell responses in mLN, sLN, blood and spleen at the indicated time points. Linear 
regression ANOVA for samples collected between 13dpi and 90dpi. C and E) 
Frequencies of granzyme B (C) and T-bet (E) expression in functional TL8 and CM9-
specific CD8+ T cell responses in matched sLN and blood samples at 13 or 90dpi. Paired, 
one-tailed Student’s t-test; 13dpi (TL8; n=9 pairs and CM9; n=12 pairs) and 90dpi (TL8 
and CM9; n=3 pairs). Lines connecting data points represent longitudinally collected data 
56		
Figure 2-10 continued: from sLN and blood of individual animals. * p<0.05 , ** p<0.01. 
No significant differences “ns”. 
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Tissue-specific T-bet dysregulation is associated with declining cytolytic SIV-specific 
CD8+ T cell functional responses during acute infection 
We next evaluated T-bet expression in functional SIV-specific CD8+ T cell 
responses in blood, sLN, mLN, and spleen as shown in Figure 2-10d. We observed 
similar T-bet expression kinetics among the functional subset of SIV-specific CD8+ T 
cells as compared to the total tetramer+ responses in LN, where declining expression 
followed peak acute phase at 13dpi (Figure 2-10d and Figure 2-8b).  However, unlike 
total tetramer+ SIV-specific CD8+ T cells from blood, the functional subset of SIV-
specific CD8+ T cells from blood expressed higher levels of T-bet at peak response, 
which declined somewhat as infection progressed during the contraction of functional 
responses to chronic SIV infection (Figure 2-10d and Figure 2-10b).  Unlike total 
tetramer+ SIV-specific CD8+ T cells, T-bet expression was significantly higher in blood 
as compared to sLN during acute infection, and in CM9-specific responses during 
chronic infection (Figure 2-10e).  T-bet expression was also higher in TL8-specific 
responses from blood during chronic infection in 2 out of 3 animals. The loss of T-bet in 
functional cells over time also extended to granzyme B expressing subsets within the 
SIV-specific CD8+ T cells in nearly all animals in all tissues (Figure 2-11a). Similar to 
total responses, functional responses expressing granzyme B had a higher frequency of T-
bet in responses from blood as compared to sLN throughout infection (Figure 2-11b).  
These data show that the association between T-bet and cytolytic granzyme B expression 
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in the functional subsets SIV-specific CD8+ T cells is heightened in circulating responses 
compared to LN.  
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Figure 2-11 T-bet expression in cytolytic SIV-specific functional responsive CD8+ T 
cells 
A) Frequencies of T-bet expression in cytolytic (GrzB+) functional SIV-specific CD8+ T 
cell responses from blood, sLN, mLN and spleen at the indicated time points. Linear 
regression ANOVA for samples collected between 13dpi and 90dpi. B) Frequencies of T-
bet expression in cytolytic SIV-specific CD8+ T cell responses in matched sLN and 
blood at 13dpi and 90dpi. Paired, one-tailed Student’s t-test; 13dpi (n=10 to 12 pairs) and 
90dpi (n=3pairs).  
Lines connecting data points represent longitudinally collected data from sLN and blood 
of individual animals. * p<0.05 ,  ** p<0.01. No significant differences “ns”. 
60		
Transcriptional requirement for maintenance of granzyme B expression following 
degranulation is dysregulated during chronic infection 
To evaluate the role of T-bet in the maintenance of granzyme B within functional 
SIV-specific CD8+ T cells, we assessed whether granzyme B expression in degranulating 
SIV-specific CD8+ T cells was preferentially maintained in T-bet expressing cells. As 
shown in Figure 2-12a and b, degranulating SIV-specific CD8+ T cells that express T-bet 
were significantly higher in granzyme B expression levels during the acute phase in both 
blood and sLN compared to T-bet negative cells.  However, after establishment of 
chronic infection, this relationship was lost. Regardless of T-bet expression, 
degranulating SIV-specific CD8+ T cells fail to express high levels of granzyme B in 
both blood and sLN. Similar observations were made for both TL8 and CM9-specific 
CD8 responses indicating that this loss of proper regulation of cytolytic factor expression 
occurs independent of epitope specificity and viral escape patterns.  
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Figure 2-12 T-bet expression sustains cytolytic potential following degranulation 
during acute infection 
A) Flow cytometry plots of T-bet and CD107a staining in CD8+ T cells following in 
vitro SIV peptide (Tat-TL8 or Gag-CM9) stimulation at the indicated time points from 
blood and sLN. Gated frequencies represent the percentage of T-bet+ or T-bet-events 
among CD107a bright events. Histograms of granzyme B expression in CD107a bright, 
T-bet+ (blue) and T-bet- (red) CD8+ T cell responses corresponding to the above flow 
cytometry plot. Gated regions indicate the frequency of granzyme B+ events (MFI of 
granzyme B in parenthesis) from the indicated parent gate above. B) MFI of granzyme B 
in matched CD107a bright, T-bet+ and T-bet-, events from blood and sLN at the 
indicated time points. Paired, one-tailed Student’s t-test; 13dpi (n=9 to 12 pairs) and 
90dpi (n=3pairs). * p<0.05 ,  ** p<0.01, and ***p<0.0001. No significant differences 
“ns”. 
62		
Chapter 2.4 Discussion 
It has long been appreciated that CD8+ T cells play a critical role in controlling 
viremia during acute and chronic SIV infection. However, the mechanisms underlying 
the ineffectiveness of CD8+ T cells to mediate control as disease progresses have 
remained unclear. Recent studies of acute HIV infection from our group have highlighted 
cytolytic HIV/SIV-specific CD8+ T cell responses developing in peripheral blood very 
early in acute infection, but subsequently losing cytolytic factor expression following 
resolution of acute viremia (130, 159). To date, most studies have primarily characterized 
CD8+ T cell responses from peripheral blood; however, viral replication occurs primarily 
in tissues such as SLT and gut mucosa. As such, it is unknown if HIV/SIV-specific 
cytotoxic CD8+ T cell responses are present in critical anatomical locations during acute 
infection, and if so, whether these responses decline or are maintained after acute 
infection.  
In the current study, we investigated the evolution of SIV-specific CD8+ T cells 
from blood, LN, spleen and gut mucosa of SIV infected RM during acute infection and 
through the transition to the chronic phase.  We found that the cytolytic proteins perforin 
and granzyme B were initially expressed in SIV-specific CD8+ T cells in tissues where 
viral replication and reservoir are established during the earliest phases of infection.  
However, this early expression of cytolytic proteins collapsed following peak CD8+ T 
cell response in all anatomical sites as infection progressed, due in part to an inability to 
maintain high levels of the transcription factor T-bet, a known regulatory factor of CD8+ 
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T cell cytolytic functions.  Overall, the short-lived cytolytic profile of SIV-specific 
responses within tissues suggests that cytotoxic T lymphocyte dysregulation is initiated in 
the earliest responses with suboptimal induction of cytolytic factor expression in SIV-
specific CD8+ T cells during acute infection leading to insufficient maintenance of CTL 
responses.   
In addition to declining expression of cytolytic proteins in SIV-specific CD8+ T 
cells following peak viremia, we found tissue-specific disparities in expression of 
perforin, granzyme B, and the transcription factor T-bet that provide some resolution to 
the previously described observation of poor effector functions in CD8+ T cells from LN 
tissue during chronic HIV infection (157).  Our detection of both lower T-bet and 
cytolytic protein expression in the earliest SIV-specific CD8+ T cells in sLN as compared 
to blood suggest tissue-specific downregulation of cytolytic factor expression and/or 
impaired replenishment following degranulation in these responses. Importantly, these 
tissue-specific expression profiles are detected in both TL8 and CM9-specific CD8+ T 
cell responses, possibly supportive of extrinsic, tissue-induced regulation of T-bet as 
opposed to intrinsic regulation mediated by TCR signaling or availability of cognate 
antigen. These results suggest that SLTs provide an environment where CD8+ T cell 
ability to directly eliminate infected cells is hampered, favoring establishment and 
persistence of HIV reservoirs. As such, it is likely that CD8+ T cell surveillance within 
lymphoid tissues is mediated in part by non-cytolytic CD8+ T cell functions (97, 98).  
Declining levels of T-bet in peripheral blood virus-specific CD8+ T cells have 
been shown to parallel the loss of cytolytic factor expression and disease progression in 
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chronic HIV, HCV and HBV infections (129, 130). The early induction of perforin and 
granzyme B co-expression in SIV-specific CD8+ T cells in the absence of high levels of 
T-bet and even in T-bet deficient cells, suggest that alternate mechanisms are likely 
involved in regulating the initial cytolytic program.  This alternatively regulated 
induction may be driven by other transcription factors including Eomes, Blimp1, or 
Runx3 as previously described (102, 103). Importantly, the short-lived co-expression of 
perforin and granzyme B implies that initial high and persistent levels of T-bet, may be 
necessary to maintain cytolytic factor expression.  Indeed, while SIV-specific CD8+ T 
cell responses expressing T-bet initially maintained granzyme B expression following 
degranulation in responses from SLT and blood, later in infection T-bet expression 
became de-coupled from granzyme B re-expression in stimulated SIV-specific CD8+ T 
cells.  These results point to additional regulatory deficiencies within SIV-specific CD8+ 
T cells that result in an inability to maintain cytolytic activity.  
It is well accepted that T cell exhaustion occurs in chronic HIV/SIV infection 
(133, 138, 164, 165). However, it is unclear how early manifestations of exhaustion first 
appear.  Experiments in mouse models suggest that even during the acute phase of 
clone13 chronic LCMV infection, there are early indicators of exhaustion (127). Here, by 
90 dpi, we can already observe an inability of SIV-specific CD8+ T cells to upregulate 
granzyme B after stimulation.  A similar observation was previously made in chronic 
HIV infection by Migueles and colleagues (83). Importantly, we now show that this 
develops extremely rapidly, in both blood and lymphoid tissue, and that at least one cause 
of this dysfunction is the de-coupling of granzyme B expression from T-bet regulation. 
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While we did not measure markers of exhaustion, such as PD-1, due to their association 
with T cell activation during acute infection (30, 127, 166) it is clear that this de-coupling 
is not simply due to chronic antigen-specific stimulation, as the same inabilities are 
manifest in the Tat-TL8 response, which escapes by 20dpi, and the Gag-CM9 response 
which does not escape. Importantly, having now found that this functional disparity also 
occurs in the RM SIV infection model, we can begin to explore interventional means to 
prevent or reverse this dysfunction and thereby determine whether maintaining properly 
regulated cytolytic effector functions in SIV-specific CD8+ T cells can modulate 
progression outcome. 
Here, we have described for the first time the very early, uniform, and precipitous 
loss of granule-mediated cytolytic properties of SIV-specific CD8+ T cells that occurs 
not only in peripheral blood, but also at key viral replication and reservoir sites within 
lymphoid tissue and gut mucosa. The inability for SLT and gut mucosa SIV-specific 
CD8+ T cells to effectively maintain cytolytic properties may foster seeding of viral 
reservoir and replication in lymphoid follicles under limited immune pressures. These 
results have broad implication in the setting of therapeutic HIV reservoir reactivation 
strategies, as even re-invigorated HIV/SIV-specific CD8+ T cell responses in lymphoid 
tissue may inherently not be capable of eliminating reactivated latently infected CD4+ T 
cells.  More generally, these findings may address important features of CD8+ T cell 
differentiation that limit full acquisition and maintenance of effector capacity within 
critical sites for HIV-specific immune surveillance.  
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Chapter 3:  Distal accumulation of SIV-specific effector 
memory CD8+ T cells from lymphoid tissues during acute SIV 
infection in Rhesus Macaques 
Chapter 3.1 Abstract 
Effector CD8+ T cells efficiently clear virus infected cells via cytolytic killing 
functions. Poor cytolytic effector CD8+ T cell functions are associated with persistence 
of HIV/SIV infection during chronic progressive infection (83, 85, 86, 131, 132).  
However, the development and expansion of HIV/SIV-specific effector CD8+ T cells in 
tissues harboring virus during the acute phase of infection has not been defined. Using 
the RM SIV infection model, we monitored the expansion, activation and development of 
SIV-specific CD8+ T cell memory responses throughout acute infection. While we 
observed the development and expansion of SIV-specific memory CD8+ T cell responses 
at sites of infection (lymph nodes and gut mucosa), we detected low levels of active 
retention of SIV-specific CD8+ T cells in SLT where preferential concentration of 
effector memory responses was detected in the circulation. Importantly, we observed 
persistent but low levels of effector memory responses with cytolytic potential in lymph 
nodes and gut mucosa during acute phase of infection, unlike those detected in blood and 
spleen. Importantly, the kinetics of SIV-specific memory subset distribution and 
cytotoxic potential were independent of epitope specificity and viral escape patterns.  
These data highlight low retention or recruitment of cytotoxic effector memory CD8+ T 
cells to sites harboring virus suggesting a mechanisms by which virus avoid effector 
mediated clearance and establishes persistence. 
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Chapter 3.2 Introduction 
Following primary HIV/SIV infection, high levels of immune activation including 
CD8+ T cell activation develop and persist into the chronic phase of infection (6, 167, 
168). Recent work has described high levels of CD8+ T cell activation concurrent with 
immense expansion of memory CD8+ T cells in peripheral blood during the acute phase 
of HIV infection (130). However, the evolution of CD8+ T cell memory differentiation 
and localization to critical anatomical locations where viral reservoir and replication 
occur is limited. Specifically, the development of SIV-specific effector and effector 
memory CD8+ T cells in close proximity to cells harboring virus is of the most interest.  
However, the presence of these CD8+ T cells thought necessary to mediate clearance of 
infected cells has not been determined. 
Importantly, HIV/SIV infected subjects demonstrating optimal control of virus, 
termed elite controllers, downregulate pro-inflammatory signals and maintain a unique 
activated CD8+ T cell phenotype following resolution of acute phase viremia in the 
absence of antiretroviral therapy (169, 170). At the same time, elite controllers develop 
more classical virus-specific CD8+ T cell memory responses in peripheral blood that 
remain functionally responsive to viral antigen stimulation and thus correlate with control 
of viremia (85, 86, 131, 132, 140, 169). These findings highlight the importance of proper 
regulation of acute phase CD8+ T cell activation that fosters proper memory 
differentiation and ultimately control viremia. 
The development of a robust effector memory CD8+ T cell response is paramount 
for clearing infected cells and establishing long-lived memory. Sufficient virus-specific 
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effector/effector memory CD8+ T cells are expanded and migrate to infected tissues to 
mediate clearance of infected cells following activation in SLT (171, 172). Upon 
clearance or control of infection, reduced immune activation drives attrition of effector 
CD8+ T cells and simultaneous expansion of the central memory CD8+ T cell repertoire. 
This process is highly regulated and imperative to maintain the integrity of the immune 
system, including proper establishment of memory responses. 
The ability of virus-specific CD8+ T cells to reach anatomical locations where 
infected cells reside is imperative for maximum desirable effector potential.  Similarly, 
surveillance by central memory cells via re-circulation through SLT is essential for 
functional long-lived immunity. Primary immunodeficiencies in factors mediating 
lymphocyte trafficking manifest in the inabilities to clear ubiquitous viral infections such 
herpes and papilloma viruses that are otherwise managed immunological memory in 
healthy individuals (173, 174). However, whether memory CD8+ T cells are retained or 
recruited to infected tissues during HIV/SIV infection is unknown. Classical efferent 
trafficking of effector and memory CD8+ T cells out of SLT poses concerns around 
CD8+ T cell mediated clearance of HIV/SIV infected follicular CD4+ T cells. 
The current model of efficient HIV/SIV viral reservoir eradication is centered on 
CTL-mediated clearance.  This subset of CD8+ T cells express cytotoxic proteins and are 
almost always phenotypically effector/effector memory differentiated (171). However, 
the presence of SIV-specific CTL outside of the peripheral blood compartment during 
acute phase of HIV/SIV infection has not been well defined. As such, mapping the 
evolution and tissue-distribution of effector memory CD8+ T cell responses throughout 
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infection will help determine whether CTL can reasonably be predicted to mediate 
optimal clearance of virus infected cells. 
In this study, we sought to define the evolution of effector memory SIV-specific 
CD8+ T cell responses during acute SIV infection through longitudinal monitoring of 
SIV infected RM. To address this, RM were infected with a high does of SIVmac251 iv 
and monitored from pre-infection up until chronic phase of infection. We characterized 
activation, cycling and memory differentiation of two dominant SIV-specific CD8+ T 
cell responses to Tat-TL8 and Gag-CM9 epitopes in peripheral blood and anatomical 
compartments closely associated with viral reservoir and replication (mLN, sLN, spleen, 
and gut mucosa). We found differentially high levels of cycling within the SIV-specific 
subset of CD8+ T cells as compared to total CD8+ T cells in all evaluated tissues during 
acute phase of infection. We found the highest levels of effector memory SIV-specific 
CD8+ T cells in the circulation and spleen, and the lowest levels in LN tissues during 
acute phase of infection in part due to limited retention of SIV-specific CD8+ T cells. 
During the transition to chronic infection, we identified a memory population resembling 
tissue resident memory CD8+ T cells in SLT that was not detectable during acute 
infection. Most importantly, the effector CTL with cytotoxic potential are limited in 
tissues harboring virus and active replication that may foster viral persistence.  
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Chapter 3.3 Results 
Transient activation and cycling of SIV-specific CD8+ T cell in critical anatomical 
locations despite persistent infection 
To assess the level of activation and expansion and retention of SIV-specific 
CD8+ T cells during acute infection, we monitored the expression of CD69 and Ki67 
throughout acute phase of the infection. We detected CD69 expression in TL8 and CM9-
specific CD8+ T cells in blood, LNs, and spleen during acute infection (Figure 3-1a). We 
observed the lowest levels of CD69 expression in TL8 and CM9-specific CD8+ T cells in 
SLT during the peak response, at 13dpi (Figure 3-1b). Interestingly, we detected an 
increasing proportion of SIV-specific CD8+ T cells expressing CD69 during the 
transition to chronic phase of infection where the highest levels were observed between 
41 and 90dpi (Figure 3-1b). Unlike SLT, we detected persistent, low levels of CD69 
expressed on SIV-specific CD8+ T cells in the blood throughout infection, with the 
exception of a few animals that transiently expressed higher levels of CD69 during the 
peak response.  
We detected Ki67 expression in TL8 and CM9-specific CD8+ T cells during 
acute infection in blood, SLT and gut mucosa (Figure 3-1a). We observed the highest 
levels of Ki67 in TL8 and CM9-specific CD8+ T cells during the peak CD8+ T cell 
response, at 13dpi, followed by a decline in frequency of expression, and therefore 
cycling in blood, SLT and gut mucosa during the transition to chronic infection and as 
CD8+ T cell responses contracted (Figure 2-5, and Figure 3-1a, c and d). Notably, CM9-
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specific CD8+ T cells in gut mucosa appeared to maintain higher levels of Ki67 into late 
acute phase of infection, at 41dpi, unlike those with TL8-specificity (Figure 3-1d).  TL8-
specific responses in gut mucosa rapidly lost Ki67 in concert with viral escape patterns 
(Figure 2-3b and Figure 3-1d). Importantly, the kinetics of Ki67 were independent of 
epitope specificity, but appeared to be highly dependent on anatomical location. 
Lastly, we compared the kinetics of CD69 and Ki67 expression in TL8 and CM9-
specific CD8+ T cells with those among total CD8+ T cells.  We found the overall 
kinetics of CD69 expression to be similar between SIV-specific and total CD8+ T cells, 
where frequencies of expression in total CD8+ T cells fell between those detected in 
CM9 and TL8 responses (Figure 3-1e). On the contrary, we observed unique kinetics of 
Ki67 expressed in TL8 and CM9-specificic responses that were not detected in total 
CD8+ T cells, which might otherwise be expected during bystander activation (Figure 
3-1e). Collectively, these data show that SIV-specific CD8+ T cells have a short-lived 
activated cycling phase during acute SIV infection.  
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Figure 3-1 SIV-specific CD8+ T cells are activated during acute infection.  
A) Flow cytometry plots of CD69 and Ki67 expression in TL8 (Red) and CM9 (Blue) 
tetramer+ CD8+ T cells from blood, sLN, mLN, and spleen at the indicated time points at 
the indicated time points. Tetramer+ events are overlaid on total CD8+ T cells (black) in 
that sample. Data are from representative animals. B and C) Kinetics of CD69 (B) and 
Ki67 expression (C) in TL8 and CM9 tetramer+ CD8+ T cells in blood, sLN, mLN, and 
spleen throughout infection.  Lines connecting data points represent longitudinal 
monitoring from a single animal. D) Kinetics of Ki67 expression in TL8 and CM9 
tetramer+ CD8+ T cells in rectal biopsies throughout infection. E) Average frequencies 
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Figure 3-1 continued: (± SEM) of CD69 and Ki67 expression in SIV-specific and total 
CD8+ T cells in the indicated tissues throughout acute phase of infection. 
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Tissue retention of functional SIV-specific CD8+ T cells develops during chronic 
phase of infection 
We next looked to evaluate the relationship between cycling, activation and 
retention in SIV-specific CD8+ T cells during the acute phase of infection. During peak 
response, we observed similar expression profiles of Ki67 and CD69 on SIV-specific 
CD8+ T cells in LN and spleen as shown in Figure 3-2a. Importantly, during the peak 
expansion and activation of SIV-specific CD8+ T cells (peak Ki67+), we observed the 
lowest frequency of CD69 among cycling CD8+ T cells that however progressively 
became inverse as infection progressed to the chronic phase (Figure 3-2b).  
These data describe limited retention capacity of the most recently activated and 
cycling SIV-specific CD8+ T cells in the SLT, yet progressive retention of cells that 
resemble Trms as infection progresses to the chronic phase.  
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Figure 3-2 Non-cycling SIV-specific CD8+ T cells are retained in SLT following 
acute phase of infection.  
A) Mean frequencies (+/- SEM) of CD69 and Ki67 expression on TL8 and CM9 
tetramer+ CD8+ T cells throughout infection from blood, sLN, mLN, and spleen. B) 
Frequencies of Ki67 expression in CD69+ TL8 and CM9 tetramer+ CD8+ T cells in 
blood, sLN, mLN and spleen throughout infection. Lines connecting data points represent 
longitudinally monitored animals. 
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Tissue-specific compartmentalization of CD8+ T cells is associated with poor 
retention of effector memory SIV-specific CD8+ T cells in lymph nodes  
We next sought to evaluate the development and tissue distribution of SIV-
specific memory CD8+ T cells during acute infection in blood, sLN, mLN, spleen and 
gut mucosa. We detected effector, transitional and central memory differentiated SIV-
specific CD8+ T cells in all evaluated tissues during acute infection as shown in Figure 
3-3a and b. We observed an expansion and predominant representation of effector 
memory TL8 and CM9-specific CD8+ T cells as compared to central and transitional 
memory differentiated cells in blood and spleen during the peak of acute infection in the 
blood and by 41dpi in spleen (Figure 3-3c Figure 3-3e). Subsequent to peak response, we 
observed a decline in the proportion of effector memory SIV-specific CD8+ T cells in 
blood reaching similar frequencies of central and transitional memory CD8+ T cells 
during the transition to chronic phase of infection (Figure 3-3c and 3-3e). Similar kinetics 
of effector memory CD8+ T cells were detected among total memory CD8+ T cells in 
blood and spleen (Figure 3-3c).  
At the same time however, we observed low frequencies of effector memory 
differentiated SIV-specific CD8+ T cells in sLN and mLN throughout acute infection that 
persisted into chronic infection (Figure 3-3c). Similar kinetics of effector, transitional and 
central memory differentiated total memory CD8+ T cells were detected in sLN and 
mLN throughout acute infection (Figure 3-3c and Figure 3-3e). Among responses in the 
gut mucosa, we detected moderate, but persistent levels of effector memory differentiated 
SIV-specific CD8+ T cells throughout infection (Figure 3-3d).  
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We next compared the representation of each memory subset of SIV-specific 
CD8+ T cells between blood and sLN, and identified tissue-specific differences in 
memory representation during acute phase of SIV infection.  We observed a lower 
proportion of central memory differentiated SIV-specific CD8+ T cells in blood as 
compared to those in sLN during acute infection (Figure 3-3f). Conversely, we detected a 
significantly greater proportion of effector memory differentiated TL8 and CM9-specific 
CD8+ T cells in blood as compared to matched sLN. Significantly greater frequencies of 
transitional memory TL8-specific CD8+ T cells were detected in sLN as compared to 
matched blood during the acute phase of infection, however no significant differences in 
the frequencies of transitional memory CM9-specific CD8+ T cells were detected 
between blood and sLN during acute phase of infection.    
These data indicate limited accumulation of effector memory SIV-specific CD8+ 
T cells in LN tissues and gut mucosa harboring virus where effector CD8+ T cells are 
thought necessary to mediate clearance of infected cells or control of virus replication. 
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Figure 3-3 Tissue-specific distribution of SIV-specific memory CD8+ T cells 
throughout infection.  
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Figure 3-3 continued: A) Flow cytometry plots of CD28 and CD95 expression on TL8 
(Red) and CM9 (Blue) tetramer+ CD8+ T cells in blood, sLN, mLN and spleen at the 
indicated time points pre- and post-infection. Tetramer+ events are overlaid on total 
CD8+ T cells (black) within that sample. Data shown are from representative animals. 
Phenotypic identification of memory subsets by CD28, CD95 and CCR7 are shown. B) 
Flow cytometry plots of CD28 and CD95 expression on TL8 and CM9 tetramer+ CD8+ 
T cells from rectal biopsies at the indicated time points pre- and post-infection. C and D) 
Frequencies of Central memory (cMem), Effector memory (Eff Mem), and Transitional 
memory (Tr Mem) differentiated SIV-specific and total CD8+ T cells in (C) blood, sLN, 
mLN and spleen, and (D) rectal biopsies at the indicated time points throughout infection. 
Lines represent mean values of the indicated subsets (+/- SEM). E) Frequencies of the 
indicated memory subsets among TL8 and CM9 tetramer+ CD8+ T cells during acute 
(13dpi) or chronic (90dpi) phases of infection in blood and sLN. Students t-test, corrected 
for multiple comparisons, 13dpi (n=? pairs) and 90dpi (n=? pairs) F) Frequencies of Eff 
Mem, cMem, and Tr Mem differentiated tetramer+ CD8+ T cells in blood and matched 
sLN at 13dpi (n=? pairs) and 90dpi (n=3 Pairs).  One tailed, paired students t-test. ). 
*p<0.05, **p<0.01, ***p<0.0001. 
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Accumulation of functional responsive effector memory CD8+ T cells distal to 
tissues harboring virus  
We next monitored the frequencies of central, transitional and effector memory 
differentiated CD8+ T cells among cytokine producing (IFNγ and TNF) and 
degranulating (CD107a staining) SIV–specific CD8+ T cell responses following in vitro 
SIV peptide stimulation. 
We detected high frequencies of effector memory differentiated TL8 and CM9-
responder CD8+ T cells in blood and spleen during acute infection that subsequently 
declined in the blood yet persisted in spleen as infection progressed to the chronic phase 
(Figure 3-4a and b). At the same time, we observed persistent, low frequencies of effector 
memory differentiated TL8 and CM9-responder CD8+ T cells in sLN and mLN during 
acute and chronic phases of infection (Figure 3-4b).  
Importantly, a significantly higher proportion of effector memory as compared to 
central and transitional differentiated TL8 and CM9-responder CD8+ T cells were 
detected in blood during acute infection that however did not persist into the chronic 
phase of infection (Figure 3-4c). Conversely, we observed significantly lower levels of 
effector memory as compared to central or transitional memory differentiated TL8 and 
CM9- responder CD8+ T cells responses in sLN during acute infection (Figure 3‑4c).   
Similar TL8 and CM9-specific CD8+ T cell memory subset distributions in sLN were 
observed among total tetramer+ SIV-specific CD8+ T cells during acute infection as 
shown in Figure 3-3c and 3-3e. As such, these data describe limited accumulation of 
functionally responsive SIV-specific effector memory CD8+ T cells in tissues harboring 
81		
virus where their functions are thought most efficacious to mediate clearance of infected 
cells. 
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Figure 3-4 Functional effector memory SIV-specific CD8+ T cells are best 
represented in the circulation.  
A) Flow cytometry plots of CD28 and CD95 expression on TL8 (Red) or CM9 (Blue) 
peptide responder SIV-specific CD8+ T cells from blood, sLN, mLN and spleen during 
acute and chronic phases of infection from representative animals. Peptide responder 
CD8+ T cells are overlaid on total CD8+ T cells within that sample. B) Frequencies of 
cMem, Eff Mem, and Tr Mem differentiated TL8 and CM9 peptide responder CD8+ T 
cells in blood, sLN, mLN, and spleen throughout infection. Lines represent average 
representation of each memory subset. C) Frequencies of memory subsets among TL8 
and CM9 peptide responders CD8+ T cells in blood and sLN at 13dpi and 90dpi. Student 
t-test, corrected for multiple comparisons. *p<0.05, **p<0.01, ***p<0.0001. 
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Aberrant cytolytic factor expression in SIV-specific memory CD8+ T cells during 
acute SIV infection 
Cytolytic CD8+ T cell functions are typically present in effector and effector 
memory CD8+ T cells to mediate clearance of target cells, and generally absent from 
central memory CD8+ T cells (46, 171). We monitored the memory distribution of 
cytolytic, Perf+GrzB+, SIV-specific CD8+ T cells throughout infection and detected 
perforin and granzyme B expression in central, transitional and effector memory 
compartments in blood, LN, spleen and gut mucosa during SIV infection (Figure 3-5a 
and b). We observed a preferential effector memory profile of Perf+GrzB+ SIV-specific 
CD8+ T cells in blood and spleen during acute phase of infection that contracted as 
infection progressed (Figure 3-5c) At the same time, we detected persistent low levels of 
effector memory Perf+GrzB+ TL8 and CM9-specific CD8+ T cells in sLN, mLN and gut 
mucosa during acute infection (Figure 3-5c and Figure 3-5d). Surprisingly, CM9-specific 
CD8+ T cells in mLN gained effector memory responses as infection progressed to the 
chronic phase.  On the other hand, we consistently detected the lowest proportion of 
Perf+GrzB+ SIV-specific CD8+ T cells as central memory differentiated cells in all 
tissues with the exception of CM9-specific CD8+ T cells in blood and sLN (Figure 3-5c).  
We next compared the proportion of memory responses between matched blood 
and sLN during acute and chronic phases of infection.  We detected a significantly higher 
proportion of effector memory Perf+GrzB+ SIV-specific CD8+ T cells in blood as 
compared to matched sLN during acute infection, but not during chronic phase of 
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infection (Figure 3-5e)  Conversely, we observed a significantly higher proportion of 
central memory Perf+GrzB+ SIV-specific CD8+ T cells in sLN as compared to blood 
during acute infection.   However, this was last as infection progressed to the chronic 
phase of infection.  Overall, few differences in transitional memory Perf+GrzB+ SIV-
specific CD8+ T cells were detected except in TL8-specific CD8+ T cells.  
Collectively, these data show preferential localization of cytolytic effector 
memory SIV-specific CD8+ T cells to the blood and spleen during the acute phase of 
infection, but not to LN tissues or gut mucosa where viral reservoir and replication in 
CD4+ T cells is present.  
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Figure 3-5 Cytolytic SIV-specific CD8+ T cells are limited in lymph nodes during 
acute SIV infection.  
A) Flow cytometry plots of CD28 and CD95 expression in TL8 (Red) and CM9 (Blue) 
tetramer+ CD8+ T cells co-expressing perforin and granzyme B from blood, sLN, mLN, 
and spleen at 13dpi and 90dpi. Cytolytic tetramer+ events are overlaid on total CD8+ T 
cells (black) from that sample. Representative flow plots are shown. B) Flow cytometry 
plots of CD28 and CD95 expression in granzyme B expressing tetramer+ CD8+ T cells 
from rectal biopsies at 13dpi and 41dpi, where TL8 and CM9 tetramer+ events are 
overlaid on to total CD8+ T cells from that sample. Representative data plots are shown. 
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Figure 3-5 continued: C) Frequencies of cMem, Eff Mem, and Tr Mem differentiated 
Perf+GrzB+ TL8 and CM9 tetramer+ CD8+ T cells from blood, sLN, mLN and spleen 
throughout infection. Lines represent average representations of the indicated memory 
subsets D). Frequencies of cMem, Eff Mem, and Tr Mem differentiated GrzB+ TL8 and 
CM9 tetramer+ CD8+ T cells from rectal biopsies throughout infection. Lines represent 
average representations of the indicated memory subsets E) Frequencies of Eff Mem, 
cMem and Tr Mem differentiated Perf+GrzB+ TL8 and CM9 tetramer+ events from 
matched blood and sLN at 13dpi and 90dpi. One tailed, student t-test. *p<0.05, **p<0.01, 
***p<0.0001 
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Chapter 3.4 Discussion 
Correlates of CD8+ T cell effector functions and control of viremia during 
HIV/SIV infection have been well described. However, the kinetics and tissue 
distribution of these efficacious SIV-specific effector memory CD8+ T cells during the 
earliest acute phase of HIV/SIV infection have not been defined. Robust expansion of 
effector memory HIV-specific CD8+ T cells was recently reported in peripheral blood 
during acute HIV infection that however declined following resolution of peak viremia 
(130). Importantly, it is unknown whether the cytolytic subset of effector CD8+ T cells 
are present in infected tissues where they are thought necessary to mediate clearance of 
HIV/SIV viral reservoir. 
Here we monitored the activation, potential for tissue retention and memory 
differentiation of SIV-specific CD8+ T cells in blood, sLN, mLN, spleen and gut mucosa 
throughout acute phase of SIV infection.  We found high levels of cycling in SIV-specific 
CD8+ T cells in all tissues, yet a poor indication for active retention of these cells in SLT 
during the peak CD8+ T cell response. We conversely detected memory CD8+ T cells in 
SLT during chronic infection that preferentially expressed CD69 in the absence of recent 
cycling indicating active retention. Throughout acute infection, we detected tissue-
specific distribution patterns of SIV-specific memory CD8+ T cells, where contrary to 
classic distribution of pathogen-specific CD8+ T cells at sites of infection, few effector 
memory SIV-specific CD8+ T cells were present in LN and gut mucosa. Conversely, 
preferentially localized in blood and spleen irrespective of epitope specificity and 
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cytolytic factor expression. Critically, SIV-specific memory CD8+ T cells with cytolytic 
potential are generated but are not concentration at anatomical sites where viral reservoir 
and replication occur. 
Similar to previous findings, elevated levels of cycling in SIV-specific CD8+ T 
cells during acute infection were lost following resolution of peak viremia (163, 175, 
176). This loss in cycling maybe due to several factors but most pertinent to SIV 
infection may be the loss in cognate antigen or the induction of immune exhaustion. 
However, the paralleled kinetics of cycling occurred independently of epitope specificity 
and viral escape patterns. In Chapter 2 we confirmed the early escape of TL8 and the 
persistence of CM9 canonical epitopes as previously reported by others (115, 116)(see 
Chapter 2). Collectively, these findings suggest homeostatic mechanisms are initiated to 
reduce expansion of activated SIV-specific CD8+ T cells to ultimately achieve systemic 
immune homeostasis and prevent tissue pathology despite persistent antigen. 
While the expression of CD69 has historically been used as an outward and 
visible sign of recent lymphocyte activation in vitro, the true known function for CD69 is 
rather involved in tissue retention (177-179). Our findings of low CD69 expression 
among SIV-specific CD8+ T cells in SLT during peak response fits with the model for 
efferent trafficking of newly activated CD8+ T cells from SLT for migration to site of 
infection. An alternate interpretation might be viewed as expansion of SIV-specific CD8+ 
T cells that predominantly lack CD69, reducing the overall frequency of CD69+ SIV-
specific CD8+ T cells while the true absolute counts may be unchanged or even elevated. 
Nevertheless, these data suggest an overall reduction in retained SIV-specific CD8+ T 
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cells in infected tissues that is likely unfavorable for increasing the probability of 
encountering and clearing an infected CD4+ T cell(s). Moreover, limited retention of 
SIV-specific CD8+ T cells in SLT during acute infection indicates fewer cells available 
for clearance of infected cells. 
Although acute phase retention of SIV-specific CD8+ T cells in SLT appears 
limited, accumulation of SIV-specific CD69+ CD8+ T cells during the transition to 
chronic phase of the infection that predominantly lack indicators of cycling or recent 
activation suggests seeding of tissue-resident memory cells at these sites of infection. 
Recent studies have identified a population of tissue-resident memory LCMV-specific 
CD8+ T cells in LNs and spleen following LCMV infection in mice, identified 
phenotypically by expression of CD69 (74). Our observation of CD69+ SIV-specific 
CD8+ T cells developing in SLT following acute SIV infection is temporally similar to 
the development of LCMV-specific Trm following acute LCMV infection in mice and 
thus speaks to the establishment of SIV-specific CD8+ Trms during the chronic phase of 
SIV infection. Nevertheless, the retention of an SIV-specific CD8+ T cell population in 
close proximity to viral reservoir may exert pressures contributing to the maintenance of 
set point viremia.  
While the overall retention of SIV-specific CD8+ T cells at sites of infection is 
important, the representation of effector memory SIV-specific CD8+ T cells at these sites 
is equally critical. Effector memory CD8+ T cells are the most efficient at executing 
sustained cytotoxic functions. Our observations of limited representation of effector 
memory SIV-specific CD8+ T cells in LN and gut mucosa during acute infection 
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corroborate with the current model of efferent trafficking of newly generated memory 
cells from SLT following activation and priming. Not surprisingly, these findings are in 
line with previously described tissue-specific distribution of memory CD8+ T cells in 
humans and “dirty” mice (70, 76, 180).  At the same time, these data show that HIV/SIV 
infection of LN and gut mucosa CD4+ T cells does not exempt CD8+ T cells from their 
pre-programmed trafficking fate following activation, nor does it appear to affect 
recruitment of effector memory responses to LN or gut mucosa.  Importantly, high levels 
of effector memory responses detected in the spleen are almost certainly not due to 
retention of recently activated SIV-specific CD8+ T cells during peak infection (i.e. low 
CD69 expression).  Rather, these high levels imply contribution from recirculating 
effector memory responses in the splenic red pulp (75% composition of spleen) as 
opposed to those localizing to secondary lymphoid structures in the white pulp (25% 
composition of spleen). As such, our findings suggest that neither retention nor obvious 
recruitment of effector memory SIV-specific CD8+ T cells takes place in SLT and gut 
mucosa during active infection that is counterproductive for CTL to exercise effector 
mediated control of local residing viral reservoir. Further, these findings provide support 
for a semi-immune privileged site of the SLT, fostering viral reservoir seeding and 
persistent replication. 
While effector memory CTL CD8+ T cells are not present at high levels in SLT 
or gut mucosa during peak acute infection, transient cytolytic factor expression among all 
memory subsets may suffice for resolution of peak viremia, and establishment of viral set 
point. Cytolytic factor expression in central, transitional and effector memory 
91		
differentiated SIV-specific CD8+ T cells has previously been described following T cell 
activation indicative of comprehensive cytotoxic efforts (181). Despite the effort to 
achieve rapid and sufficient cytolytic capacity in CD8+ T cells during acute infection, the 
transcriptional profiles of central and transitional memory responses are not equipped to 
sustain cytolytic factor expression, as seen with the loss in cytolytic factor expression in 
SLT and gut mucosa discussed in Chapter 2.  For good reason, the expression of cytolytic 
factors is tightly regulated. This regulation prevents bystander destruction of lymphoid 
tissue architecture, and prolonged imbalance to the chemokine gradient required to 
sustain follicular and germinal center organization albeit while infection persists. 
In this study we described the accumulation of effector memory SIV-specific 
CD8+ T cells in the circulation as opposed to SLT where infection in concentrated. While 
the rapid expansion and efflux of effector responses and collapse in cytolytic potential 
(Discussed in Chapter 2) of SIV-specific CD8+ T cells from SLT may be counter 
productive for clearance of infected CD4+ T cells in SLT follicles, the immune system 
does exert pressure on the virus (viral escape discussed in Chapter 2), resolve peak 
viremia and maintain some control of the infection as indicated by stable set point 
viremia.  These findings suggest that alternate mechanisms other than cytolysis are 
involved in the partial control of this persistent infection.  
These findings have implications in the feasibility of SIV-specific CTL to mediate 
clearance of infected cells and viral reservoir in SLT and gut mucosa. Aside from the 
predicted consequences of poor CTL potential in SLT, an effort to maintain partial 
control of viremia must be in place. Reasonably, the source of persistent immune 
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pressure on viral reservoir in SLT may be derived from the tissue resident memory 
(CD69+Ki67-) SIV-specific CD8+ T cell population that accumulates in SLT as infection 
progresses to the chronic phase. 
Overall, preferential localization of effector memory cytotoxic CD8+ T cells at 
distal to sites of infection supports the designation of SLT as a semi-immune privileged 
site. Specifically and most importantly, the maintenance of this designation, even during 
local acute infection, is favorable to survival of HIV/SIV, yet has serious negative 
consequences related to persistence of the infection.  Although dampened cytotoxic 
effector capacity at sites of infection, a memory CD8+ T cell population resembling 
tissue resident memory is likely involved in partial control of viremia via non-cytotoxic 
mechanisms. 
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Chapter 4:  Discussion and Future Directions  
Chapter 4.1 Summary of findings 
Our study aimed to characterize aspects of cytotoxic CD8+ T cell effector 
potential to further define attributes of the earliest SIV-specific CD8+ T cell responses 
that are in part influential to the chronicity of HIV/SIV infection. First, we identified an 
acute phase restricted expansion and activation profile of SIV-specific CD8+ T cells, as 
compared to total CD8+ T cells. This transient profile was detected despite persistence of 
viremia where we might otherwise anticipate continued activation and expansion of SIV-
specific CD8+ T cells. Second, we observed robust cytolytic potential of SIV-specific 
CD8+ T cells in blood, LNs, spleen and gut mucosa, all tissues that are critically involved 
in HIV/SIV persistence, at peak acute infection that was however short-lived and 
collapsed following the peak CD8+ T cell response. Importantly, the kinetics of SIV-
specific CD8+ T cells were independent of epitope specificity and viral escape patterns. 
We found expression and persistence of cytolytic factors, perforin and granzyme B, to 
parallel the expression of the regulatory factor T-bet during acute and chronic phases of 
infection. Specifically, we observed low and declining levels of T-bet in SIV-specific 
CD8+ T cells.  Third, we identified tissue specific disparities between SIV-specific CD8+ 
T cells in the blood, LNs, spleen and gut mucosa that were also independent of epitope 
specificity or persistence of cognate antigen. These disparities include lower expression 
of perforin and reduced maintenance of T-bet expression in SIV-specific CD8+ T cells in 
lymphoid tissues as compared to peripheral blood. Lastly, during the transition to chronic 
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phase of infection we identified a decoupling of T-bet expression and the ability to 
replenish cytolytic factor granzyme B following degranulation suggestive of a 
mechanism for reduced CTL potential.   
In addition, we aimed to characterize the kinetics and tissue distribution of 
effector memory SIV-specific CD8+ T cells that are thought to traffic to infected tissues 
and execute optimal effector functions for clearance of infected CD4+ T cells.  
Overwhelmingly, we detected low frequencies of effector memory differentiated CD8+ T 
cells in tissues harboring high levels of virus. At the same time, we detected limited 
retention of recently activated, cytolytic SIV-specific CD8+ T cells in SLT where their 
functions are predicted necessary to mediate clearance of infected CD4+ T cells. 
Interestingly however, during the transition to chronic phase of infection, we identified 
accumulation of SIV-specific CD8+ T cells that phenotypically resemble Trms. We 
hypothesize that these Trms may contribute to the maintenance of set point viremia via 
non-cytolytic functions. Further, we identified central and transitional memory 
differentiated SIV-specific CD8+ T cells with untypical or aberrant cytolytic factor 
expression among the earliest detectable responses from all evaluated tissues 
demonstrating an exemplary effort by the immune system for granular-mediated 
cytotoxic clearance of infected CD4+ T cells. 
Indeed, our findings have allowed us to make implications on early dysregulation 
of the CD8+ T cell cytotoxic effector function yet an effort to establish local immune-
surveillance as infection progresses to the chronic phase. Most importantly, these 
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observations in crucial anatomical sites harboring virus elucidate several tissue specific 
mechanisms of immune-suppression that foster the chronic nature of HIV/SIV infection.  
Chapter 4.2 Implications of findings 
Chapter 4.2.1 Implications for tissue specific restraint on CD8+ T cell effector 
capacity and persistence of viral reservoir 
Our study addresses some of the gaps in understanding CD8+ T cell cytotoxic 
profiles in anatomical locations where viral reservoir and replication are known to be 
highly concentrated. The functional capacity of CD8+ T cell effector responses within 
SLT are thought to be poor during chronic HIV/SIV infection and include limited 
accessibility to target infected cells. These inferior and insufficient CTL functions are 
hypothesized to be consequential of an immune privileged environment established in the 
SLT (120, 122, 157, 160). However, the mechanisms and context in which this semi-
immune privileged environment manifest are unknown.  
We first addressed a critical question of whether the immune system actually can, 
and does generate cytolytic CD8+ T cell effector responses to SIV during the initial phase 
of infection and found that these responses were generated. Chiefly, we next addressed 
whether these responses are ever present where they are thought to be most functionally 
essential to mediate clearance of infected cells, including LN, spleen and gut mucosa 
(120). Our detection of qualitatively inferior cytotoxic CD8+ T cell responses in LN as 
compared to matched peripheral blood during acute phase of infection highlights the 
disparities of immune functions between these two compartments.   
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These disparities include significantly lower perforin for pore formation in target 
cells, refractory granzyme B replenishment following degranulation and lower 
frequencies of T-bet expressing functionally responsive SIV-specific responses. These 
distinctions highlight the importance of comprehending disparities in anatomical location 
and environments when looking to evaluate circulating responses as surrogate for tissue 
residing responses. At the same time, these findings can generate new interpretations of 
many previously published studies that may clarify and facilitate a new model for 
understanding HIV/SIV persistence and immune evasion. For example, peripheral blood 
has historically served as a surrogate for monitoring the systemic immune compartment 
during HIV/SIV infection. Using peripheral blood, several groups, including our own, 
have reported superior cytotoxic functionalities of HIV/SIV-specific CD8+ T cells in 
elite controller subjects as compared to lower levels detected in chronic progressors. 
However, data in this thesis suggest that cytotoxic functionalities in tissue harboring virus 
are lost early during the acute phase of infection. As such, the focus on granule-mediated 
cytolysis as the responsible mechanism for the establishment and maintenance of set 
point viremia should be challenged in both elite controller and chronic progressive 
subjects. Additionally, the strategy of reactivation of viral reservoir with HDAC 
inhibitors (Discussed in Chapter 2) depends heavily on the assumption that CTL can 
reach viral reservoir in SLT and gut mucosa, and upon arrival can mount robust cytotoxic 
killing functions. The data in this thesis challenges the feasibility of this therapeutic 
strategy.   
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It is important that we note our study did not include evaluation of absolute 
cytolytic killing functions, nor factors associated with dampening of the effector 
functions in lymphoid tissues. Rather, these studies evaluated the phenotypically defined 
effector memory cells and expression of factors necessary for mediating granule-
mediated cytolysis and functional responsiveness to stimulation with SIV peptides.  
These approaches allowed us to determine whether and to what degree SIV-specific 
CD8+ T cells from various critical anatomical compartments have cytotoxic potential, 
respond to peptide stimulation and maintain this profile over time. We did not evaluate 
signals induced by tissue residing cells, such as fibroblasts or dendritic cells, that may be 
associated with dampening of T cell activation, nor did we evaluate inhibitory receptors 
that may be associated with receiving such signals (i.e., PD-1, 2B4, Lag-3 among others). 
Nevertheless, we have resolved the question of whether acute phase SIV-specific CD8+ 
T cells in anatomical locations harboring viral reservoir express necessary factors for 
granule mediated cytolysis (Perf+GrzB+) and sustain an efficacious effector CD8+ T cell 
profile (T-bet). Collectively, these data provide support for defining LN as semi-immune 
privileged tissue and highly suggest that virus avoids immune pressures in these tissues to 
establish long term reservoir (Figure 4-1).  
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Figure 4-1 Proposed tissue-specific expression of cytotoxic genes during acute SIV 
infection 
A proposed model of tissue-specific expression intensity of the cytolytic factors in SIV-
specific CD8+ T cells evaluated in this study.  
99		
 
Chapter 4.2.2 Implications for retention/sufficiency of effector responses in infected 
secondary lymphoid tissues. 
Our detection of limited retention and accumulation of effector memory 
differentiated SIV-specific CD8+ T cells in LN tissues (Discussed in Chapter 3) has 
implications in the sufficiency of local cytolytic responses for clearance of HIV/SIV 
infected cells. Current models of CD8+ T cell memory differentiation and expansion 
describe efferent trafficking of recently activated and primed T cells from lymphoid 
tissue to sites of infection via the circulation (Figure 4-2). This migration out of SLT is in 
place for efficient delivery of effector cells to infected tissues and immediate systemic 
surveillance by central memory cells. Similarly, during primary SIV infection, the 
majority of newly generated effector memory SIV-specific CD8+ T cells in SLT do not 
express retention markers and are found concentrate in the circulation. Ideally, retention 
of effector CD8+ T cells in SLT during acute HIV/SIV infection will more efficiently or 
completely eliminate infected cells and prevent establishment of viral reservoir. 
Conversely, limited retention of SIV-specific CD8+ T cells would be counter-productive 
for CTL-mediated clearance of infected cells in these tissues as we and others have 
reported (Figure 4-2). 
Importantly, our study did not define the absolute changes in CD8+ T cells that 
demonstrate retention capabilities (CD69) or effector memory phenotypes (CD28-
CD95+CCR7-). As such, the changes that we observed in the proportion of these cells 
may not reflect absolute numbers of these populations in the evaluated tissues. 
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Nevertheless, SIV is highly concentrated in CD4+ follicular T cells and thus CD8+ T 
cells, whether newly activated and primed, or recently differentiated from long-lived 
memory cells should be actively retained in these infected. Along these lines, this study 
did not determine the consequences of retaining SIV-specific CD8+ T cells in LN or 
spleen to evaluate whether retention or accumulation of these responses at sites of 
infection positively influences clearance of infected cells and viral reservoir. Currently, 
our lab is designing a RM SIV infection study to address this question using FTY70 
small molecule inhibitor of lymphocyte egress from SLT. 
 Our findings imply that the default fate of activated SIV-specific CD8+ T cells to 
egress from SLT is not redirected towards retention or accumulation of effector memory 
responses even in the presence of local lymphoid tissue infection. Moreover, the lack of 
effector memory accumulation at these infected sites lessens the probability for CTL to 
encounter target infected cells and implies yet another route by which the virus avoid 
immune clearance.  
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Figure 4-2 Proposed model of CD8+ T cell activation and memory distribution as it 
relates to highly infected tissues during acute SIV infection in rhesus macaques 
A) Proposed model for SIV-specific memory CD8+ T cell distribution in anatomical sites 
harboring viral reservoir and replication during acute SIV infection. B) Modeled kinetics 
of total and SIV-specific CD8+ T cell responses (TL8 and CM9 dominant epitopes) in 
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Figure 4-2 continued: anatomical compartments harboring virus during acute and 
through the transition to chronic phase of infection. Pre-infection CD8+ T cell memory 
subset distributions are shown for blood, gut mucosa and LN. 
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Chapter 4.2.3 Implication for T-bet dysregulation of cytotoxic functions 
Undoubtedly our results suggest dysregulation of cytolytic factor expression and 
replenishment in association with T-bet expression in SIV-specific CD8+ T cell 
responses during early infection. Our observations in LN and blood describe the 
paralleled loss in replenishment of granzyme B following degranulation of SIV-specific 
CD8+ T cells in the absence of T-bet expression. Additional observations in peripheral 
blood described decoupled T-bet expression with the ability to maintain granzyme B 
expression following degranulation during chronic phase of infection. These findings 
imply that active mechanisms may be in place to suppress T-bet functions to sustain 
cytolytic profiles in SIV-specific CD8+ T cell responses as infection progresses.  
Our observations and interpretations around T-bet and cytotoxic factor expression 
are limited. We did not evaluate other possible regulators of the effector program such as 
Rux3, Blimp1, or Eomes among others. However, it is well established that T-bet 
expression is indispensible for maintaining the robust expansion and functionality of 
effector CD8+ T cells as shown by many. The decoupling of T-bet from maintenance of 
granzyme B is suggestive of induction of the early induction immune exhaustion.  
Although, this study did not characterize the induction kinetics of immune exhaustion as 
discussed in Chapter 2.4 and again in Chapter 4.2.4. We can speculate that negative 
regulation of cytolytic factor expression may overcome positive regulation by T-bet 
during the transition to chronic phase of infection. Such mechanisms may include 
negative regulation by Bcl-6, PD-1 or TGFβ induced regulation or possible regulation at 
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a translational level. Reasonably, multiple mechanisms working together may 
collectively present in this decoupling.  
These findings contribute to hypotheses around regulation and dampening of 
effector functions that contribute to chronicity of HIV/SIV infection. Further, 
transcriptional dysregulation of the effector program by T-bet is closely linked to the idea 
of an immune privileged site ripe for viral reservoir persistence, yet be a necessary 
regulatory process for host survival. 
Chapter 4.2.4 Implications in immune homeostasis 
A biological necessity is implicit in the short-lived cytolytic factor expression and 
limited retention of effector CTL in lymphoid tissues. We propose that mechanisms of 
homeostasis are influential in the evolution of SIV-specific CD8+ T cell effector 
responses as early as the acute phase of HIV/SIV infection. The synchronous collapse in 
cytolytic factor expression and near uniform kinetics of T-bet expression in SIV-specific 
CD8+ T cell responses in blood, LN, spleen and gut mucosa during acute phase of SIV 
infection are highly suggestive of induction of immune homeostasis or even of the state 
of immune exhaustion.  
Paralleled kinetics between TL8 and CM9-specific CD8+ T cells that experienced 
either loss (TL8) or persistence (CM9) of cognate antigen imply a default induction of 
immune regulation.  Such mechanisms could include downregulation of type I interferons 
and interferon stimulated genes, positive regulation of anti-inflammatory profiles 
including expansion of T regulatory cells and anti-inflammatory cytokine including 
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TGFβ, IL-10 among others. Anti-inflammatory mechanisms throughout the acute phase 
of infection should be investigated in particular the temporal relationship to the collapse 
in the cytotoxic profiles during early acute HIV/SIV infection. 
Evidence for immune exhaustion has been evaluated during the chronic phase of 
HIV/SIV infection (133, 138, 182), however little known about the evolution of immune 
exhaustion as early as the acute phase of infection. It may be implicit in these findings 
that some aspects of CD8+ T cell exhaustion are initiated during this early phases of 
infection (discussed in Chapter 2). However, evidence suggesting a more global 
induction of immune homeostasis is discussed above. The classical environment for 
CD8+ T cell exhaustion describes addiction or dependence of exhausted CD8+ T cells on 
cognate antigen for survival despite lack of responsiveness or effector functions (183, 
184). This description of chronic antigen stimulation despite poor effector functionality 
does not fit with the full escape of canonical TL8 epitope by 20dpi. Indicators of immune 
exhaustion including PD-1, 2B4, Lag3, CD160, TIGIT among others, were not evaluated 
in this study, yet deserve attention as immune exhaustion my play a critical role in 
chronicity of infection and/or the rate of disease progression.   
Although homeostatic regulation of immune activation and effector functions 
appears counter productive for control of HIV/SIV infection, especially in cells proximal 
to infection, this early establishment may be critical for the survival of the host. Sustained 
activation and cytotoxic activity may be more detrimental to the host in comparison to 
chronic, persistent infection. However, these states of immune regulation and 
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homeostasis were not evaluated in this study, and thus can only be commented on with 
speculation. 
Chapter 4.2.5 Alternative non-cytolytic mechanisms for control of viremia during 
chronic phase of infection 
Our current understanding of granule-mediated cytolytic CD8+ T cell killing 
requires direct contact with the target infected cell via the immunological synapse, thus 
elevating the importance of CTL in close proximity with target infected cells. While we 
observed transient cytolytic potential in SIV-specific CD8+ T cells in all evaluated 
tissues and limited representation of effector memory responses in LN, virus persisted at 
the achieved set point viremia. These findings imply that alternate mechanisms are 
responsible for maintaining set point viremia in the absence of SIV-specific CD8+ T cell 
cytotoxic killing capacity. In fact, prior studies have proposed and provided evidence for 
non-cytolytic mediated suppression of viral replication by CD8+ T cells during chronic 
infection (97, 98, 123).  
While none of these alternate mechanisms were evaluated in the present study, 
their role certainly fits with the kinetics of CTL and the control of set point viremia. Non-
cytolytic mechanisms that may mediate this process include alpha/beta defensins, 
Mip1α/β, TNF and the unclassified factor CAF (8, 80, 92-94). The contribution of these 
non-cytolytic factors certainly could account for the maintenance of set point viremia in 
the near absence of cytotoxic potential and retained effector memory SIV-specific CD8+ 
T cells in SLT. Regulation of viral replication in this manner may prevent high levels of 
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immune activation and therefore serve the host in a more efficient, less disruptive 
fashion. As such, we contribute new hypotheses around non-cytolytic mechanisms of 
control of HIV/SIV replication during chronic phase of infection that may be initiated as 
early as the acute phase of SIV infection (Discussed in Chapter 2).  
Chapter 4.2.6 Impact in efficacy of therapeutic intervention: Reinvigoration 
strategies for viral reservoir clearance may be challenging. 
Beyond control of primary HIV/SIV infection, the collapse and refractory 
expression of cytolytic factors in SIV-specific CD8+ T cells following recall response 
has profound implications for therapeutic HIV reservoir reactivation strategies. The 
theoretical success for clearance of reactivated latent HIV/SIV reservoirs depends heavily 
on CTL mediated killing (83, 85, 86, 115, 118, 131, 132, 169). This strategy implies 
dependence on expansion, recruitment and retention of CTL to tissue harboring 
reactivated reservoir (LN and gut mucosa) and sustained cytotoxic functionality therein. 
The distinct results from our study uncover several concerns for the feasibility of 
reinvigorating memory CD8+ T cell responses at sites of infection for efficacious CTL-
mediated clearance of viral reservoir.  
Although validation of virus-specific CD8+ T cell responses in SLT during acute 
HIV infection have not been done, Demers et al. recently showed loss of cytotoxic 
potential in HIV-specific CD8+ T cells from peripheral blood during acute HIV infection, 
validating our results in blood during acute SIV infection in RM (130). Undoubtedly, 
CTL kinetics will hold true in critical anatomical locations during HIV infection in 
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patients. Moreover, it questionable and appears unlikely that upon reactivation of HIV 
latent reservoirs HIV-specific memory CD8+ T cells will rapidly provide fully 
programmed and uninhibited CTL effector responses to sites of infection. Briefly, T cell 
based vaccine or gene therapy approaches may experience similar hurdles around tissue-
specific immune regulation, diverting robust effector CD8+ T cells responses from 
residing in target, infected, tissues.  
Chapter 4.2.7 Implications for effector CD8+ T cell development 
More generally, our findings address important features of CD8+ T cell memory 
development. Specifically, restraint on expansion of effector responses and full 
acquisition of effector potential may be in place prior to arrival in peripheral blood. This 
observation contains features that resemble the phenomenon of lineage priming during 
hematopoiesis, where genes involved in lineage specification and commitment can be 
transiently expressed, albeit at low levels, prior to de-repression of genes required for that 
fate, and subsequent full acquisition of that fate potential (185). We hypothesize that 
lymphoid tissue priming of CD8+ effector T cell differentiation includes low expression 
of genes that are involved in establishing effector identity which are actively de-repressed 
until a contextual or environmental cue is received.  
Our lab is currently characterizing lymphocytes from thoracic duct fluid to 
confirm the repressed effector profile of CD8+ T cells prior to reaching peripheral blood 
in HIV negative and positive subjects. Results from this study thus far provide evidence 
for restricted effector profiles of memory CD8+ T cells prior to reaching the peripheral 
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blood circulation. At the same time, identification of this contextual or environmental 
cue(s) is under investigation in our lab and includes evaluating the expression of cytolytic 
factors and transcription factors that regulate them.   
Reasonably, differentiation and full acquisition of effector functions in lymphoid 
tissues could be dangerous for survival of APCs presenting cognate antigen. In addition, 
the effector capacity maybe deleterious to tissue architecture and the essential balance of 
chemokine gradients for new memory formation. (See Chapter 4.2.3) 
Chapter 4.2.8 Conclusions and Discussion 
Here, we characterized several properties of SIV-specific CD8+ T cells that have 
otherwise previously been undefined during acute HIV/SIV infection. Most strikingly is 
an exemplary yet short-lived effort by the immune system to initiate granule-mediated 
cytolytic potential in nearly all SIV-specific memory CD8+ T cells during the acute 
phase of infection. Despite this effort, full expression of cytotoxic factors in SIV-specific 
CD8+ T cells in lymphoid tissue and gut mucosa is dampened as compared to those 
detected in the circulation. We hypothesize this tissue-specific restraint on cytotoxic 
potential along with limited indicators of their retention is in place for lymphoid tissue 
preservation. Particularly, this restraint may minimize tissue pathologies associated with 
apoptosis and inflammation following execution of granule-mediated cytolysis and the 
release of cytotoxic factors in the local environment. Importantly however, neither the 
efficacy nor toxicity of retained cytotoxic effector CD8+ T cells at sites of infection were 
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evaluated in this study. Nevertheless, we speculate these CTL dampening and self-
preservation mechanisms cultivate the immune-privileged environment of these tissues. 
While the immune system demonstrates cytotoxic potential and activity, as 
indicated by resolution of peak viremia during acute phase of the infection, this potential 
becomes diminished from nearly all SIV-specific CD8+ T cells in all tissues as infection 
progresses to the chronic phase. We propose this synchronous collapse in cytolytic 
potential is driven by cell intrinsic and extrinsic mechanisms to contain immune 
activation, although exact mechanisms responsible for early onset CTL dysregulation 
have not been evaluated, yet deserve attention. Certainly, CD8+ T cell exhaustion may 
contribute to this phenomenon. Supporting evidence for this hypothesis is seen in the 
independence of this phenomenon from epitope specificity, viral escape patterns, and 
anatomical location as well as the uncoupling of T-bet from granzyme B expression in 
degranulated functional CD8+ T cell responses.  
Importantly, how set point viremia is maintained in the absence of robust 
cytotoxic CD8+ T cells is not understood. Non-cytolytic CD8+ T cell effector 
mechanisms are hypothesized to mediate this partial control of HIV/SIV that may include 
CAF (Discussed in Chapter 1), although a mechanism(s) responsible for non-cytolytic 
CD8+ T cell mediated control has not been identified (97, 98, 123). Our data indirectly 
support this hypothesis but do not address this question directly. Curiously, the 
accumulation of Trm SIV-specific CD8+ T cells at sites of infection during chronic phase 
of infection is a likely source of non-cytolytic functions for partial control of viremia. 
Trms reside at sites of infection and in SLT following acute infection. These resident 
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cells provide rapid response to rechallenge or viral replication through various effector 
mechanisms including non-cytolytic. As such, we can reasonably speculate that Trms 
participate in the control of set point viremia during chronic HIV/SIV infection. 
In summary, we show that the immune system provides an illusion of a well-
equipped, initial response to HIV/SIV infection through memory differentiation, 
expansion and generation of cytotoxic CD8+ T cells (Figure 4-3). However, early 
dysregulation in cytotoxic potential driven in part by T-bet dysregulation along with 
limited retention of effector memory SIV-specific CD8+ T cells in tissue harboring virus 
provide an explanation for the early establishment of viral reservoir in these tissues 
(Figure 4-3 and Figure 4-4). While we observe a collapse in CD8+ T cell cytotoxic 
potential, despite persistence of infection, a second line of CD8+ T cell defense 
responsible for maintaining partial control of infection (set point viremia) may be 
mediated by SIV-specific Trm CD8+ T cells that accumulate at these sites following 
resolution of acute viremia.   
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Figure 4-3 Model of CD8+ T cell cytolytic representation in critical anatomical 
compartments during SIV infection in RM  
Tissue distribution of cytolytic CD8+ T cell in critical anatomical compartments 
including blood, lymph node, spleen, and gut mucosa during SIV infection in RM; acute 
phase (A) and chronic phase (B).  The relative proportions of non-cytolytic and cytolytic 
SIV-specific CD8+ T cells are shown in blood, lymph node, spleen and gut mucosa 
during SIV infection; acute phase (A) and chronic phase (B).  
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Figure 4-4 Model of SIV-specific CD8+ T cell cytolytic profile in SLT during acute 
SIV infection in RM  
Comparative frequencies and expression intensities of critical components of cytotoxic 
CD8+ T cells and their potential to clear virus infected CD4+ T cells in secondary 
lymphoid tissue during peak SIV infection (acute phase) and throughout the transition to 
the chronic phase of infection. Expression intensity of the indicated components is 
represented by the intensity of shading, where darker shades represent higher expression 
and lighter shades represent lower expression. 
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Chapter 4.3 Future Directions 
Chapter 4.3.1 Identifying tissue-specific cytotoxic and suppressive functional 
capacities of CD8+ T cells during acute SIV infection 
The cytolytic factor perforin is differentially expressed in SIV-specific CD8+ T 
cells between SLT and blood, and granzyme B replenishment following degranulation 
during in vitro stimulation is most refractory in responses from LN. Defining true 
cytotoxic and antiviral functions of SIV-specific CD8+ T cell responses from blood and 
tissues against virus infected CD4+ T cells will more directly define tissue-specific 
disparities in cytotoxic potential and the ability to execute this potential. Critically, 
determining whether SIV-specific CD8+ T cells in tissues harboring viral reservoir in fact 
do carry out killing, or can mediate suppressive antiviral functions will solidify our 
hypothesis around tissue induced dampening of CTL functions. We propose functional 
target cell killing and suppression assays that can address these gaps in understanding 
CTL potential in various anatomical compartments.  We are currently in the process of 
obtaining results from an in vitro viral suppression assay using sLN and peripheral blood 
samples collected in this study.   
Chapter 4.3.2 Expression of genes involved in cytolytic functions 
The short-lived cytolytic factors expression in the absence of T-bet suggests 
alternate transcriptional regulatory mechanisms involved in driving the initial SIV-
specific CTL profile (Discussed in Chapter 2). In addition, differential expression of 
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perforin, granzyme B and T-bet in SIV-specific CD8+ T cells between blood and SLT 
suggest yet another undefined mechanism of CTL regulation. We propose gene transcript 
analysis for each of these factors, perforin, granzyme B and T-bet in SIV-specific CD8+ 
T cells from each of the studied tissue compartments (blood, LN, spleen, gut mucosa). 
The evaluation of perforin, granzyme B, and T-bet may inform possible transcriptional 
regulation of these factor is addition to our protein analysis by flow cytometry. We 
propose to evaluate transcripts of possible alternate transcription factors involved in 
regulation of cytolytic factor expression as well as those that might be involved in active 
repression of the effector network including Eomes, Blimp-1, Runx3, Bcl-6, Tcf1, Foxo1 
and many others. Nevertheless, gene transcript studies may help define mechanisms of 
immune dysregulation or mechanisms of immune suppression that are components of, but 
not limited to, the chronic nature of HIV/SIV infection.   
Chapter 4.3.3 Induction of immune exhaustion  
Some of the findings in this study may indicate CD8+ T cell exhaustion as a 
mechanism for lost cytotoxic potential during acute SIV infection (47, 127). However, 
the induction of immune exhaustion in relationship to the loss in cytolytic profiles 
throughout infection was not included in this study, yet certainly affords attention. We 
propose evaluating the evolution of inhibitory receptor expression patterns in relation to 
polyfunctionality and cytotoxic potential of SIV-specific CD8+ T cell responses 
throughout acute phase of infection. More in depth analysis of exhaustion profiles in SIV-
specific CD8+ T cell from critical anatomical compartments throughout acute SIV 
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infection should be done including transcriptional and epigenetic profiling of genes 
involved in the establishment of exhaustion (127, 128, 137, 186). These studies may too 
provide evidence for the environmental or anatomical context in which induction of 
exhaustion begins. 
Chapter 4.3.4 Tissue residing memory SIV-specific CD8+ T cells and non cytolytic 
mechanisms of control 
Based on the identification of a population of SIV-specific CD8+ T cells that 
closely resembles Trm, we propose to further evaluate the phenotype of these SLT 
residing responses. In addition to rigorously evaluating their phenotype, we propose to 
evaluate the cytotoxic and non-cytotoxic functional capacities of these cells extracted 
from tissues of chronically infected RM. A similar functional assay described in Chapter 
4.3.1 would provide details on these questions. To further evaluate the proximity of these 
SIV-specific CD8+ T cells to viral reservoir in lymphoid follicles, we propose to perform 
tissue sectioning and immunofluorescence microscopy on LN and spleen sections from 
these animals. Identification of the precise anatomical location of these Trm like SIV-
specific CD8+ T cells within SLT will provide further understanding as to their role in 
SLT tissue, and most importantly their potential role in containing virus to follicular 
regions of SLT during chronic infection. 
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Chapter 5:  Methods 
Chapter 5.1 Ethical Statement for use of non-human primates 
Procedures carried out in this study were performed following an Institutional 
Animal Care and Use Committee (IACUC) of Emory University approved protocol, 
number #YER-2002541-121716GA in accordance with the Animal Welfare Act and 
other federal statutes and regulations relating to animals. All animals were housed at the 
Yerkes National Primate Research Center (YNPRC) at Emory University (Atlanta, GA) 
following the guidelines established by the National Institutes of Health (NIH), under the 
supervision of the Association for the Assessment and Accreditation of Laboratory 
Animal Care (AAALAC)-accredited Division of Animal Resources. Housing and care for 
all animals complied with and met the standards established and written in the Animal 
Welfare Act, Animal Welfare Regulations, and The Guide for the Care and Use of 
Laboratory Animals (8thEdition).  All tissue sample collections were performed under 
anesthetization using Ketamine (10 mg/kg IM) or Telazol (5 mg/kg IM) to minimize 
suffering. No pre-scheduled sacrifice or death of animals was occurred in this study. 
Reduction of stress was provided through enrichment activities such foraging for grains, 
KongTM toys, as well as other enrichment strategies to animals in need as determined by 
the YNPRC veterinary and/or care staff. Additionally, animals were housed in paneled 
cages so as to provide some social interaction and contact with one another including 
grooming and other social activities, when feasible. 
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Chapter 5.2 Animals 
Eighteen healthy, SIV-uninfected, Mamu-A*01-positive (MHC-class I) Indian 
rhesus were used in this study. RM selected for this study were 32-38 months old (males 
(n=13) and females (n=5)), and Mamu B*01 and Mamu B*17-negative to exclude 
animals with predispositions for control of viremia.  Animals selected for the study were 
quarantined for 30-45 days in accordance with the YNPRC IACUC prior to the start of 
the study. Animals underwent staggered necropsy post SIV infection during acute 
infection at 5, 10, 13, 20, or 41 days post-infection (dpi), or during chronic infection at 
90dpi.  Three animals were sacrificed at each indicated time point post-infection (Figure 
2-1a and Figure 2-2a). 
Chapter 5.3 Infection and monitoring viral load  
All animals were infected with 500TCID50 SIVmac251 intravenous (iv) (10.8ng/mL 
p27) (Nancy Miller, NIAID, NIH). Whole blood was collected by venous puncture into 
EDTA blood collection tubes (BD, Franklin Lakes, NJ) for evaluating SIV viral loads. 
Plasma viremia was monitored longitudinally in all animals using quantitative real time 
PCR, with sensitivity of 60 copies/mL by the Emory University CFAR Virology Core 
facilities as previously described (187). 
119		
Chapter 5.4 Viral sequencing and analysis 
Blood plasma from two animals was evaluated between 10dpi and 90dpi for Tat-
TL8 and Gag-CM9 epitope sequence monitoring. Virus inoculum stock was evaluated to 
determine the frequencies of each epitope present at the time of infection. Between 
40,000–80,000 vRNA copies were extracted from blood plasma samples and viral 
inoculum stock using the Qiagen BioRobot EZ1 Workstation with EZ1 Virus Mini Kit 
v2.0 (Qiagen, Valencia, CA). vRNA was subject to reverse transcription using MuLV 
(SuperScript III) reverse transcriptase using the following primers; Tat-RT3:  5’ –
TGGGGATAATTTTACACAAGGC-3’ (188) and SMgag.R1:  5’-
CTACTGGTCTTCTCCAAAGAGAGAATTGA-3’ for analysis of TL8 and CM9 
epitopes, respectively. Resampling of PCR products was avoided by obtained PCR end 
point dilutions of each cDNA sample as previously described (189). Equal quantities of 
cDNA from each sample were PCR amplified to achieve the desirable sampling depth. 
Multiple bulk PCR reactions were performed and subsequently pooled to reach sufficient 
cDNA volumes when necessary. cDNA samples were analyzed using MiSeq analysis and 
amplification fragment lengths of roughly 2,035bp and 1,560bp were generated for TL8 
and CM9 epitope coding regions, respectively. PCR primers used for TL8 region 
amplification are as follows; 1st round, Fwd: smE660/mac251-int-F1 5’-
ATGAATTTTAAAAGAAGGGGAGGAA-3’, Rev: Tat-R2 5’-
CCCAAGTATCCCTATTCTTGGTTGCAC-3’ (188) and 2nd round, Fwd: 
smE660/mac251-int-F2:  5’-AAGAAGGGGAGGAATAGGGGATATG-3’, Rev: Tat-R3 
5’-GAGCAAGATGGCGATAAGCAG-3’ (188). PCR primers used for CM9 region 
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amplification are as follows; 1st round, Fwd: SIV.R.F1 5’-
TCGCTCTGCGGAGAGGCTG-3’, and Rev: SMgag.R1 5’-
CTACTGGTCTTCTCCAAAGAGAGAATTGA-3’, and 2nd round, Fwd: SIV.R.F2 5’- 
TGCGGAGAGGCTGGCAGATTGA-3’, Rev: SM.gag.R2 5’-
TCCAAAGAGAGAATTGAGGTGCAGCAA-3’. Raw sequence reads were translated 
into amino acid sequences and aligned to the SIVmac251 reference sequence. Variations 
in Tat-TL8 and Gag-CM9 epitopes were determined as compared to canonical Tat-TL8 
(TTPESANL) and Gag-CM9 (CTPYDINQM) reference amino acid sequences. The 
frequency of each detected epitope variant was determined using Geneious R9 software 
(Geneious, Auckland, New Zealand). Changes in the distribution of canonical Tat-TL8 
and Gag-CM9 sequences between virus inoculum stock and chronic phase of infection, at 
90dpi, were monitored (Figure 2-3).  
Chapter 5.5 Tissue collection and lymphocyte cryopreservation 
All samples were collected at YNPRC and shipped overnight to the University of 
Pennsylvania for processing the following day, with the exception of peripheral blood 
collected for complete blood count and blood plasma viral load analysis. Tissues were 
collected from each animal at the indicated time points pre- and post-infection (Figure 
2-1a and Figure 2-2a).  Peripheral blood, axillary and inguinal superficial lymph nodes 
(sLN), and rectal biopsies (RB) were collected longitudinally from each animal, while 
spleen and mesenteric lymph nodes (mLN) were collected at necropsy only. Peripheral 
blood was collected by venous puncture into EDTA or sodium heparin blood collection 
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tubes (BD, Franklin Lakes, NJ). Blood collection volumes were taken in the IACUC 
approved sample volumes at the indicated time points pre- and post SIV infection.  
Superficial LN samples were collected under general anesthesia by surgery at the 
indicated time points pre- and post SIV infection.  Samples were stored in sterile R-10 
media (Rosewell Park media (RPMI) (Mediatech Inc, Manassas, VA), supplemented with 
10% fetal bovine serum (FBS), Penicillin/Streptomycin, L-Glutamine, and kept at 2-8°C 
until processing. RBs were collected under general anesthesia using a sigmoidoscope at 
the indicated time points pre- and post SIV infection. Samples were stored in sterile R-10 
media and kept at 2-8°C until processing.  Mesenteric LNs, remaining sLN, and spleen 
were collected at necropsy only. Samples were stored in sterile R-10 media and kept at 2-
8°C until processing.  
Chapter 5.6 Processing tissues 
All tissue processing was done at the University of Pennsylvania in accordance 
with University Environmental and Health Safety Guidelines under sterile conditions. 
Rectal biopsies were processed to extract intraepithelial and lamina propria residing 
lymphocytes by the University of Pennsylvania Human Immunology Core facility.  The 
extraction process included serial washes of biopsies with R-10 media plus collagenase 
XI followed by percoll 65/30 gradient for separation of lymphocytes from contaminating 
epithelial cells. Peripheral blood mononuclear cells were isolated from venous whole 
blood collected using standard Ficoll-Paque PLUS (GE Healthcare, Pittsburgh, PA) 
diluted to 90% in 1X Dulbecos Phosphate Buffered Saline (Mediatech Inc, Manassas, 
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VA), and centrifuged at 350g for 20 minutes. Spleen and LN were processed by 
mechanical disruption in 2% FBS in Dulbecos Phosphate Buffered Saline with 10U/mL 
of DNAse I (Roche Life Sciences, Indianapolis, IN) for extraction of lymphocytes. 
Splenocytes were subsequently treated with sterile ACK red cell lysis buffer (NH4Cl 
0.15M, KHCO3 10mM, EDTA 0.1mM pH 7.2-7.4 in distilled deionized water).  All 
extracted lymphocytes with the exception of those extracted from RBs were immediately 
cryopreserved in 10% DMSO (Fisher Scientific, Fair Lawn, NJ) in FBS (Gemini Bio-
Products, West Sacramento, CA) and stored at -150°C.  All RB derived lymphocytes 
were evaluated fresh. 
Chapter 5.7 Lymphocyte stimulation 
Cryopreserved lymphocytes from peripheral blood, mLN, sLN, and spleen were 
thawed and rested overnight in sterile R-10 media plus 10U/mL DNAse I (Roche Life 
Sciences, Indianapolis, IN) at 37°C, 5% CO2 and 95% humidity incubation conditions. 
Lymphocytes from blood, sLN, mLN and spleen were stimulated as described in (190) at 
1.0mL final volume in sterile R-10 media.  Peptide concentrations for stimulation 
conditions were 2µg/mL Tat-TL8 peptide (TTPESANL) or Gag-CM9 (CTPYDINQM) 
(New England Peptide, Gardner, MA). Co-stimulation was added with peptides; 1µg/mL 
anti-CD49d (9F10, Biolegend, San Diego, CA) and CD28-ECD (Clone CD28.2, 
Beckman Coulter, Brea, CA) at the start of stimulation. Positive control samples were 
stimulated using Staphylococcal Enterotoxin B (List Biological Laboratories, Campbell, 
CA) at 1µg/mL. CD107a-BV421 (Biolegend, San Diego, CA) was added at the start of 
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stimulation. Brefeldin A (1µg /mL) (Sigma Aldrich, Saint Louis, MO) and monensin 
(0.66µL/mL) (BD Bioscience, San Jose, CA) were added one hour after initiation of 
stimulation. Cells were incubated under stimulation conditions for a total of 9 hours. 
Chapter 5.8 MHC Class I Tetramers 
Tat-TL8 (TTPESANL) Mamu A*01-APC conjugated tetramers and Gag-CM9 
(CTPYDINQM) Mamu A*01 monomers were supplied by the NIH Tetramer Core 
Facility at Emory University, Atlanta, GA. Gag-CM9 Mamu A*01-BV421 tetramers 
were prepared in our laboratory using Gag-CM9 monomers and streptavidin-BV421 
(Biolegend, San Diego, CA) with protease inhibitor cocktail set I (Calbiochem, Billerica, 
MA). 
Chapter 5.9 Fluorescence cytometry staining 
Lymphocytes were stained as described in (190).  MHC class I, Mamu A*01 
tetramer staining was done at 37°C at 5% CO2 and 95% humidity for 10 minutes, 
concurrent with CCR7 staining when applicable, prior to the addition of viability dye and 
remaining antibodies for immunophenotype staining.  
Chapter 5.10 Antibodies  
The following antibodies were used for phenotyping and functional evaluation of 
lymphocytes in this study: CD107a-BV421 (H4A3, Biolegend), CD4-PECy5.5 (clone 
S3.5, Invitrogen), CD8-BV570 (Clone RPA-T8, Biolegend), CD14-BV650 (clone M5E2, 
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Biolegend), CD20-BV650 (Clone 2H7, Biolegend), CD16-BV650 (Clone 3G8, 
Biolegend), CD28-ECD (Clone CD28.2, Beckman Coulter), CD95-PECy5 (Dx2, BD 
Biosciences), CD38-PE (OKT10, NIH NHP Reagent Resource, University of 
Massachusetts, Boston, MA), CCR7- BV711 (G043H7, Biolegend). CD3-APCCy7 
(SP34-2, BD Biosciences), granzyme B-AF700 (GB11, BD Biosciences), T-bet-PECy7 
(4B10, eBioscience), Ki67-FITC (B56, BD Bioscience) or Ki67-BV786 (B56, BD 
Bioscience), CD69-APC (FN50, BD Bioscience) or CD69-BV605 (FN50, Biolegend), 
Perforin-FITC (pf344, MabTech), TNF-BV605 (MAb11, Biolegend), IFNγ-BV785 
(4S.B3, Biolegend), Live Dead Fixable Aqua Dead Cell Stain (Molecular Probes). 
Chapter 5.11 Data acquisition and analysis 
All immunofluorescence stained lymphocytes were acquired and analyzed on a 
special order LSR II Flow cytometer using BD FACS Diva Software version 6.0.1 or 
8.0.1 (Becton Dickinson, San Jose, CA).  Flow cytometry data was analyzed using 
FlowJo version 9.8.3 (Treestar, Ashland, OR).  Statistical analysis and graphs of flow 
cytometry data were performed using JMP Pro 12 (SAS, Cary, NC) or Prism v5.0 
(GraphPad Software, La Jolla, Ca).  All reported values for functional response after 
peptide stimulation were done with background (unstimulated) levels subtracted and with 
a minimum of 10 events for functional response or 25 events for tetramer responses. 
Analysis of paired samples, longitudinally or between matched tissues at a single time 
point was done by paired student t-test with alpha 0.05.  Regression ANOVA was done 
on samples collected between 13dpi and 90dpi to monitor cross sectional changes over 
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time. * indicates a p<0.05, ** indicates a p value <0.01, and *** indicates a p value 
<0.001. 
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